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ABSTRACT 
The immune system is a sophisticated organization of cells and tissues that cooperate in 
safeguarding the integrity of our body by eliminating internal and external threats. Vaccines 
are the most impactful medical intervention and have contributed tremendously to lowering 
mortality rates of infectious diseases. The protective immunity induced by vaccination is 
mediated by eliciting neutralizing antibodies that are sustained for years or even for a lifetime. 
Antibodies are produced by plasma cells, which are generated from activated and terminally 
differentiated B cells. Many processes regulating B cell development and function are under 
the regulation of the NF-κB signaling pathway. Defects in NF-κB signaling have been shown, 
using mouse models, to be detrimental to the development of distinct B cell subsets as well as 
their ability to participate in humoral responses. In humans, mutations of components in the 
NF-κB pathway are increasingly associated with common variable immunodeficiencies. In this 
thesis, the role of IκBNS, a nuclear regulator of the NF-κB pathway, was investigated to gain 
a more comprehensive understanding of B cell development and function. 
In paper I, we addressed the absence of B-1a cells in IκBNS-deficient bumble mice. We 
identified a precursor population in wildtype mice of IgM+CD93+CD19+CD5+ transitional B-
1a cells (TrB-1a), which exhibited other indicators of B-1 lineage commitment, such as natural 
IgM secretion and increased Igλ expression. We did not detect TrB-1a cells in bumble mice 
whereas the neonatal B-1 progenitor cell (B-1p) population was intact. These results indicate 
that IκBNS is required for the transition from B-1p to the TrB-1a stage. In paper II, we 
investigated potential reasons for the impaired T cell-independent (TI) responses in bumble 
mice. We found impaired expression of the surface receptor TACI, which is essential in 
responses to TI antigens, and reduced responsiveness to its ligands in bumble mice. In addition, 
bumble B cells did not fully silence Pax5 expression and exhibited rapid upregulation of Blimp-
1 during early division cycles. Thus, these results suggest that IκBNS is involved in TACI 
expression and function as well as in transcriptional regulation of PC differentiation. In paper 
III, we used nfkbidB- mice in which IκBNS was selectively depleted from B cells to distinguish 
between B cell intrinsic and extrinsic defects in T cell-independent (TD) responses. NfkbidB- 
mice exhibited normal GC formation, but antigen-specific antibodies of the IgG2c and IgG3 
isotype were reduced. Hence, IκBNS appears to be important for class switching during TD 
responses. In paper IV, we developed a protocol for evaluation of plasma cell differentiation 
from human primary B cells. Cells that exhibited a phenotype resembling plasma cells were 
identified as CD38+IRF4hiPax5lo and CD38+IRF4intPax5lo. Both populations were generated 
when starting from fresh or cryopreserved samples, or isolated memory and naïve B cells. 
Application of the methods developed in this paper to patient samples could provide more 
insight into mechanisms underlying immune disorders. 
Collectively, the results of this thesis contribute to our understanding of processes that are 
fundamental to establishing adequate humoral responses and are of direct relevance to 
immunodeficiency disorders. 
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1 INTRODUCTION 
 
This thesis addresses the role of IκBNS, a nuclear regulator of the NF-κB pathway, in B cell 
development and function. This chapter provides background information relevant to the field 
of B cell immunology and the work presented in this thesis. 
1.1 Overview of the immune system 
The immune system consists of a wide variety of molecules, cells, and tissues that collaborate 
towards the common goal of protecting the body from infectious pathogens and maintaining 
homeostasis. The epithelial and mucosal surfaces outside and inside our body, antimicrobial 
peptides, acidity of the stomach, and commensal microbiota in the gut serve as a first line of 
defence. Once these barriers are breached by an invading pathogen or a wound, the immune 
system comes into play. Generally, the immune system is distinguished into two branches: 
the innate and adaptive immune system.  
The innate immune system initiates immune responses based on the recognition of foreign 
structures or altered host structures, and thereby identifies potential threats. Soluble factors 
belonging to the innate immune system include anti-microbial peptides, complement proteins, 
and natural serum immunoglobulin, which control the early phase of infection or tissue 
damage and initiates immune responses. Many immune cells express pattern recognition 
receptors (PRRs) on their cell surface that enable them to recognize pathogen-associated 
molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). PAMPs 
and DAMPs are specific to infectious pathogens and damaged host cells, respectively. 
Neutrophils, monocytes, and macrophages can eliminate pathogens and debris through 
phagocytosis, whereas natural killer (NK) cells recognize and kill infected cells and 
(pre)cancerous cells through the release of cytotoxic factors or via death ligands. 
Macrophages, dendritic cells (DCs), and B cells are referred to as professional antigen 
presenting cells (APCs) as they present antigen (Ag) on MHCII molecules to cells of the 
adaptive immune system to induce their activation, differentiation, and acquisition of effector 
functions. Key characteristics of the adaptive immune system are diversity, specificity, and 
memory. The antigen receptors of B cells and T cells are generated through recombination of 
gene segments, that allow for a high diversity of specificities in the adaptive immune 
repertoire. Moreover, B cells can undergo affinity maturation and class-switching to fine-tune 
the humoral response to the invading pathogen. CD4+ T cells promote B cell activation, 
whereas CD8+ T cells mediate cellular immunity against intracellular pathogens or eliminate 
altered cells. Both B cells and T cells can be re-programmed to become memory cells that 
circulate and survey the periphery. Upon secondary encounter of a pathogen, these memory 
cells rapidly differentiate to acquire effector functions. Due to their ability to produce highly 
effective binding and neutralising antibodies, B cells are key mediators of long-lasting 
protective immune responses induced by vaccines. 
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1.2 B cell subsets 
Mature B lymphocytes can be distinguished into three main subsets: follicular B cells (FOBs), 
marginal zone B cells (MZBs), and B-1 cells. These B cell subsets are different in phenotypic 
and functional characteristics, anatomic localisation, migratory capacity, and ontogeny. 
The B-1 cell population, also referred to as the B-1 lineage, is further subdivided into B-1a and 
B-1b cells. The generation of B-1 cells occurs predominantly in the foetal liver and wanes after 
birth. Maintenance of a stable B-1 population is dependent on in situ self-renewal (Kantor et 
al., 1995). FOBs and MZBs, commonly referred to as the B-2 lineage, are generated and 
maintained via continuous replenishment from precursor cells residing in the bone marrow 
(Osmond, 1986). B-1 and MZB cells are generally activated in a T cell-independent manner 
while follicular B cells are activated in a T cell-dependent manner. Due to the ability of 
marginal zone B cells and B-1 cells to provide early responses, they are considered to be innate-
like lymphocytes that functionally connect innate to adaptive immunity. Apart from antibody 
production, B cells also contribute to shaping the immune response by acting as APCs through 
Ag presentation on MHCII molecules and secretion of cytokines, such as IL-10. 
 
1.2.1 Follicular B cells 
Naïve follicular B cells circulate throughout the periphery and reside in follicular niches that 
are in close proximity to T cell zones in secondary lymphoid tissues, such as the spleen, lymph 
nodes, and Peyer’s patches (Allman and Pillai, 2008). Homeostasis and survival of follicular B 
cells in the follicular area is dependent on BAFFR signaling (Rauch et al., 2009). FOBs are 
important for mediating TD antibody responses to protein antigens, which requires GC 
formation (see section 1.4.3). Activation and differentiation of FOBs into antibody secreting 
cells is achieved through synergistic signals from the BCR, CD40, and TLRs (Genestier et al., 
2007). FOBs can differentiate into short-lived plasma cells during the early phase of the TD 
response, as well as become long-lived plasma cells after migration and homing to the bone 
marrow (Genestier et al., 2007).  
 
1.2.2 Marginal zone B cells 
Marginal zone B cells are important for humoral responses against blood-borne pathogens and 
can rapidly differentiate into plasmablasts and short-lived plasma cells upon antigen activation. 
MZB cells populate the splenic marginal zone near the marginal sinus, which is dependent on 
their expression of the spingosine-1-phospate receptors S1P1 and S1P3 (Kraal, 1992; Cinamon 
et al., 2004). Upon capture of antigen bound by immune complexes, MZBs can shuttle between 
the marginal zone and the follicular area for antigen presentation to naïve T cells and thereby 
promote TD responses (Attanavanich and Kearney, 2004; Cinamon et al., 2004). In addition, 
MZB cells express CD1d on their surface, which enables them to present lipid antigens to 
NK T cells and produce anti-lipid antibodies (Leadbetter et al., 2008). 
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1.2.3 B-1 cells 
B-1 cells predominantly reside in peritoneal and pleural cavities and spontaneously secrete 
polyreactive and broadly neutralizing IgM, and are therefore the main source of natural 
antibodies found in serum (Hayakawa et al., 1986). These natural antibodies have specificities 
against self-antigens, such as oxidized lipids, annexin IV and phosphatidylcholine, and thereby 
contribute to clearance of atherosclerotic lesions, apoptotic cells and cellular debris (Chou et 
al., 2009; Kulik et al., 2009). Natural IgM can also assist in the clearance of (pre)cancerous 
cells through recognition of tumour-associated proteins (Brändlein et al., 2003). The presence 
of tumour-associated IgM antibodies in patients can be used as a diagnostic tool for early 
detection of cancer (Díaz-Zaragoza et al., 2015). In addition, common viral and bacterial 
antigens containing multivalent epitopes, such as phosphorylcholine and lipopolysaccharides, 
are also detected by natural IgM (Briles et al., 1981). The important role of B-1 cells in 
maintaining homeostasis and providing the first line of defence against infections is thus 
attributed to their production of natural IgM. 
The majority of the B-1 cell lineage expresses intermediate levels of CD5 on their surface and 
are termed B-1a cells, while CD5-negative B-1 cells are termed B-1b cells (Hayakawa et al., 
1986). In addition, B-1b cells are capable of generating protective long-term TI responses to 
infectious pathogens, and thereby contribute to adaptive immunity as well (Alugupalli et al., 
2004; Haas et al., 2005). The homing of B-1 cells to the peritoneal and pleural cavity has been 
shown to depend on the chemokine CXCL13, which is produced by peritoneal macrophages 
and cells in the omentum (Ansel et al., 2002). During infections, migration of activated B-1a 
cells towards secondary lymph nodes and subsequent differentiation into IgM secreting cells is 
regulated via TLR signaling and type I IFNs, and followed by a loss of CD5 expression (Ha et 
al., 2006; Waffarn et al., 2015; Savage et al., 2019). 
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1.3 B cell development 
The production of B cells is a process that commences in utero and continues throughout life. 
B cells, like all cells in the body, are derived from hematopoietic stem cells (HSCs) and 
transition through several developmental stages before becoming functional mature B cells. 
B cell development is characterized by expression of surface markers, the assembly of the 
BCR, and selection mechanisms. It is currently thought that B cell development occurs in three 
waves; the first wave originates from the yolk sac and the para-aortic splanchnopleura and 
generates B-1 cells, the second wave stems from foetal liver HSCs and predominantly produces 
B-1 and MZBs , whereas the third wave is comprised of bone marrow HSCs which gives rise 
to mainly the B-2 lineage (Fig. 1). 
 
1.3.1 Foetal B cell development 
As early as embryonic day (E) 9.5, cells are present in the yolk sac that have the potential to 
give rise to lymphoid lineages. These yolk sac cells have been defined as CD45+c-KithiCD93+ 
but do not express Sca-1, a definitive marker of HSCs, and are therefore considered pre-
haematopoietic stem cells (pre-HSCs) (Yamane et al., 2009; Ito et al., 2013). Cells derived 
from the aorta-gonad-mesonephros (AGM) region, which develops from para-aortic 
splanchnopleura (P-Sp), are able to reconstitute multiple myeloid and lymphoid lineages, 
including B cells, before cells from the yolk sac acquire the potential to generate 
lymphomyeloid cells (Cumano et al., 1996). For this reason, the P-Sp is considered the first 
tissue to harbour B cell potential, and by E10.5, it becomes an important source of definitive 
HSCs (Taoudi et al., 2005). Around E11, HSCs migrate from the yolk sac and AGM region, 
populate the foetal liver, and undergo expansion.  
 
Figure 1. The emergence of cells in the haematopoietic system with B cell potential.  
P-Sp = para-aortic splanchnopleura, YSC = yolk sac cell, FL HSC = foetal liver haematopoietic stem 
cell, LMP = lymphomyeloid progenitor cell, B-1p = B-1 progenitor cell, Tr B = transitional B cell. 
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Here, they develop into CD45+c-KIT+FLT3+IL7Ra+ lymphomyeloid progenitor cells (LMP) 
(Böiers et al., 2013; Kobayashi et al., 2014). Distinct progenitor cells of the B-1 lineage (B-1p) 
were identified as Lin-CD45lo/-CD93+CD19+ in foetal liver at E11 already (Montecino-
Rodriguez et al., 2006). Shortly after osteogenesis is initiated in the embryo, FL HSCs migrate 
from the foetal liver to the bone marrow, where they expand and reside throughout life as adult 
HSCs. Transfer experiments of B-1p from the foetal bone marrow have shown that they 
preferentially reconstitute CD5+ B-1a cells, whereas B-1p from adult bone marrow generates 
CD5- B-1b cells(Kikuchi and Kondo, 2006). Around the time of birth and up to two weeks 
after, the neonatal spleen becomes a prominent location of B-1 cell development. 
Between 7 and 21 days of age, B-1 cells from the spleen populate the peritoneal cavity, where 
they persist through self-renewal. Once the B-1 cell population is established in the peritoneal 
cavity, contribution of adult bone marrow HSCs to this population is limited (Lalor et al., 1989).  
 
1.3.2 BCR rearrangement and selection in the bone marrow 
During B cell development the progenitor and precursor cell stages can be characterized by 
expression of surface markers as well as the rearrangement status of the membrane-bound 
immunoglobulin molecule, which is known as the B cell receptor (BCR) (Fig.2). The 
generation of the BCR is achieved through step-wise recombination of gene segments encoded 
by the immunoglobulin loci (Tonegawa, 1983). The BCR consists of two immunoglobulin 
heavy chains (IgH) combined with two immunoglobulin light chains (IgL). Both chains contain 
a constant C-terminal region that is invariable between antibodies of the same immunoglobulin 
class, while the N-terminal regions are highly variable. The variable regions are encoded by 
variable (VH), diversity (DH), and joining (JH) segments in the heavy chain. The light chain is 
only encoded by variable (VL) and joining (JL) segments. The variable regions of the heavy and 
the light chains form the antigen-binding site and determine the binding specificity of the BCR 
(Alt et al., 1987). 
The sequential DNA rearrangement of the IgH and IgL loci, a mechanism referred to as V(D)J 
recombination, is pivotal for successful assembly and expression of the BCR. V(D)J 
recombination occurs primarily in foetal liver and bone marrow in progenitor (pro-) and 
precursor (pre-) B cells (Fig. 3). First, rearrangement of the DH and JH gene segments followed 
by rearrangement of the VH gene segment to the DHJH segment in the IgH loci occurs during 
the pro-B cell stage. After successful recombination, the IgH chain associates with the 
surrogate light chain (SLC), which will lead to translocation to the cellular membrane where 
they form the pre-BCR complex together with the Igα and Igβ chains. Signaling mediated by 
the pre-BCR complex is required for pre-B cell survival and serves as a checkpoint for 
successful recombination (Mårtensson and Ceredig, 2000). 
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Subsequently, rearrangement of the IgL gene 
segments occur at the pre-B cell stage during 
which preferentially the Igκ gene loci will be 
rearranged prior to the Igλ loci. The sequential 
order of V(D)J recombination ensures that only 
one particular BCR will be expressed by a B cell, 
a mechanism which is referred to as allelic 
exclusion (Nussenzweig et al., 1987). After 
expression of a functionally rearranged BCR, the 
pre-B cell will become an immature B cell and will 
be surface IgM positive (sIgM+). These immature sIgM+ B cells migrate to the spleen, from 
where they will develop further through transitional B cell stages and mature into follicular B 
cells, marginal zone B cells, or B-1 cells (Allman and Pillai, 2008; Montecino-Rodriguez and 
Dorshkind, 2011). 
 
 
 
 
 
1.3.3 B cell receptor rearrangement 
The generation of a functional and unique BCR is dependent on the rearrangement of the 
germline V(D)J segments (Fig. 4). All V, D, and J gene segments are flanked by a 
recombination signal sequence (RSS), which are recognized by the enzymes recombination 
activating genes (RAG) 1 and 2 (Jung and Alt, 2004; Schroeder and Cavacini, 2010; Schatz 
and Ji, 2011).  RAG1 and RAG2 locate to the RSS of the gene segments that recombine 
together and introduce double-strand DNA breaks, which form closed hairpin structures. 
Endonucleases are recruited to cleave the hairpin structures to allow for ligation of the gene 
segments through the DNA repair mechanism of non-homologous end joining (NHEJ). 
Figure 3. Stages of B cell development and maturation in bone marrow and spleen and the 
corresponding status of BCR rearrangement and expression. 
Figure 2. Antibody structure. 
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During NHEJ, the two ends of the coding sequences need to be paired and thus palindromic 
sequences (P-nucleotides) could be added to enable pairing of otherwise non-matching ends. 
Additionally, the gene segment ends are exposed to exonucleases and the enzyme terminal 
deoxynucleotidyl transferase (TdT), which remove nucleotides and insert random 
N-nucleotides in the coding ends, respectively (Schroeder and Cavacini, 2010). These 
mechanisms contribute to further increase the diversity of the V(D)J junction. The diversity of 
the BCR repertoire forms the basis for our ability to mount protective immune responses to a 
broad range of infectious pathogens. 
 
 
 
 
1.3.4 Transcriptional regulation of B cell development 
The transcriptional programme that controls foetal versus adult B cell development is not well 
characterized. Lin28b is an RNA-binding protein that has recently been described as a regulator 
of B-1a cell development during foetal haematopoiesis (Kristiansen et al., 2016). Lin28b 
prevents degradation of Arid3a mRNA transcripts by the Let-7b microRNA (Zhou et al., 2015). 
Expression of the transcription factor Arid3a promotes light chain recombination simultaneous 
to heavy chain recombination in pre-B cells, enabling them to bypass the pre-BCR checkpoint 
(Hayakawa et al., 2019; Wong et al., 2019). Arid3a has also been shown to induce the 
expression of the transcription factor Bhlhe41, which is involved in the regulation of B-1a cell 
development and persistence (Kreslavsky et al., 2017; Hayakawa et al., 2019). In addition, the 
transcription factor Oct2 has been shown to regulate IL-5Rα expression in B-1 cells, thereby 
contributing to their function and survival (Emslie et al., 2008).  
 
Figure 4. Rearrangement of heavy and light chain V(D)J genes.  
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1.4 B cell activation 
B cells recognize antigen through the BCR, which is membrane-bound immunoglobulin. 
B cell activation occurs in secondary lymphoid organs where they encounter antigen and 
undergo proliferation, maturation, and differentiation. Considering the vast diversity of 
pathogens, humoral immune responses are adapted towards each individual pathogen for 
efficient clearance. The activation and differentiation of B cells largely depends on the type of 
antigen but is also influenced by interactions with other immune cells and cytokines. 
Ultimately, the quality of the antibody response is determined by antibody affinity, epitope 
specificity, titre, effector function mediated by the antibody isotype, and the kinetics of the 
response. 
 
1.4.1 T cell independent and T cell dependent responses 
Antibody responses are classified as either T cell-independent (TI) or T cell-dependent (TD) 
(Fig. 5). TI antigens are capable of inducing B cell responses in the absence of T cell help. 
TI antigens can be further designated as ‘TI type 1’ (TI-1) or ‘TI type 2’ (TI-2) antigens 
depending on whether they elicit antibody responses in CBA/N mice, which are unable to 
signal through the BCR as they are deficient in Bruton’s tyrosine kinase (Btk) (Mosier et al., 
1977). TI-1 antigens, such as lipopolysaccharide (LPS), CpG, and viral RNA, engage and 
signal through Toll-like receptors (TLRs) to activate B cells (Coutinho et al., 1974; 
Bekeredjian-Ding and Jego, 2009). TI-2 antigens are generally multivalent antigens that 
extensively ligate BCRs and thus require intact signaling through Btk in order to effectively 
activate B cells. Examples of TI-2 antigens are bacterial capsular polysaccharides from 
Streptococcus pneumoniae, Haemophilus influenza type b, and Neisseria meningitides, but also 
includes repetitive determinants on virus particles (Mond et al., 1995; García de Vinuesa et al., 
1999b). TD responses are elicited by protein antigens that are recognized specifically by the 
BCR and require additional T cell help to activate B cells. Full activation and proliferation of 
B cells in response to these antigens depends on T cell help through CD40L-CD40 interaction 
and secretion of cytokines, such as IL-21, IL-4 or IFN-γ (Bryant et al., 2007; Cannons et al., 
2010). A hallmark of TD responses is the formation of germinal centres (GCs) where B cells 
undergo affinity maturation and selection (see section 1.3.3). 
 
 
Figure 5.  B cell activation during TI and TD responses. 
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1.4.2 Extrafollicular response 
After antigen-induced activation of B cells in the spleen or lymph node, differentiation 
continues either in the follicular area as germinal centre B cells or in the extrafollicular area as 
plasmablasts (Fig. 6). B cells committing to differentiation via the extrafollicular route will 
localize at the boundary between the T cell zone and the red pulp within the spleen or the 
medullary cords within the lymph nodes (Toellner et al., 1996; Luther et al., 1997). Migration 
from the follicular zone to the extrafollicular area is mediated by CXCR4 expression, which 
increases the responsiveness to the chemokine CXCL12, and downregulation of CXCR5 and 
CCR7, which reduces their responsiveness to CXCL13, CCL19, and CCL21 respectively 
(Hargreaves et al., 2001). Migration into the extrafollicular area occurs within 24 hours of 
antigen encounter, and commitment to plasmablast differentiation is already observed at 48 
hours as evidenced by high expression of B lymphocyte-induced maturation protein-1 
(Blimp-1) which is sustained afterwards (Vinuesa et al., 2001). Extrafollicular plasmablast 
differentiation and survival is supported by CD11chi DCs and completely independent of T cell 
help (García De Vinuesa et al., 1999a). The frequency of extrafollicular plasmablasts peaks at 
day 7-8 after immunization or infection and then declines as cells undergo apoptosis (Jacob et 
al., 1991; Smith et al., 1996). The rapid generation of plasmablasts and short-lived plasma cells 
from the extrafollicular response is essential for the early control of infections, whilst adaptive 
responses are initiated. 
 
1.4.3 Germinal centre response 
Affinity matured B cells are generated through germinal centres (GCs). GCs are structural 
microenvironments induced by antigen-activated B cells in the lymph nodes and spleens 
(MacLennan, 1994; Toellner et al., 2002). Geminal centre formation is observed four days after 
antigen encounter, peaks around day 14, and declines afterwards (Toellner et al., 1996). GCs 
facilitate interaction between B cells and T helper cells (TFH cells) and follicular dendritic cells 
(FDCs) in order to support affinity maturation and selection (Garside et al., 1998; Cannons et 
al., 2010). Antigen-activated B cells exhibit induced expression of the chemokine receptors 
CCR7 and EBI2, allowing them to migrate to the border with the T cell zone where they 
encounter antigen-activated T cells (Reif et al., 2002; Pereira et al., 2009). High expression of 
the transcription factor B cell lymphoma protein 6 (Bcl-6) results in downregulation of EBI2, 
promoting B cell migration towards the centre of the follicle to initiate the GC reaction (Shaffer 
et al., 2000). In addition, migration of both B cells and TFH cells requires upregulation of 
CXCR5 and downregulation of CCR7, which are also under the control of Bcl-6 (Vinuesa et 
al., 2005). After migration of antigen-activated B cells to the interface of the T and B cell zone, 
B cells present antigen-derived peptides on MHC class II molecules to TFH cells (Victora et al., 
2010). GC B cells with increased BCR affinity are more efficient at presenting antigen to TFH 
cells, and those that are able to form stable interactions with TFH cells, as demonstrated by 
increased levels of ICAM-1 and SLAM, exhibit higher levels of IRF4 (Victora et al., 2010; Ise 
et al., 2018). 
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The GC consists of two distinct areas referred to as the dark zone and the light zone. The dark 
zone is where B cells proliferate and undergo somatic hypermutation (SHM), while the light 
zone is where affinity-based selection takes place. GC B cells induce the expression of the 
enzyme activation induced cytidine deaminase (AID) which mediates SHM and class-
switching. AID introduces random point mutations mainly into the immunoglobulin variable 
(V) region gene segments which could alter the affinity of the BCR. The processes of B cell 
selection and differentiation in the germinal centre is regulated by TFH cells and follicular 
dendritic cells (FDCs). For example, TFH cells express CD40L and thus induce CD40 signaling 
in B cells, and secrete cytokines essential for survival, differentiation, and proliferation, such 
as IL-4, IL-10, IL-21, and IL-2 (Bryant et al., 2007). In addition, GC B cells upregulate ligands 
for PD-1 and the interaction with PD-1 expressed on TFH cells and FDCs seems important for 
selection and generation of plasma cells (Good-Jacobson et al., 2010). It was shown that the 
selection pressure arises from limited availability of T cell help. GC B cells with higher affinity 
are able to take up more antigens from FDCs, and consequently present more antigen-derived 
peptides on MHC class II to T cells, thereby outcompeting cells with lower affinity (Victora et 
al., 2010). The final outcome of GC responses are plasma cells, some of which become long-
lived plasma cells upon migration and homing in the bone marrow niche where they can survive 
and confer protective immunity for years, and memory B cells that circulate through the 
periphery and induce rapid recall responses upon encountering the same or a similar antigen. 
 
1.4.4 Plasma cell differentiation 
Plasma cells (PCs) are terminally differentiated B cells that fulfil the highly specialized 
function of continuously producing and secreting antibodies. The morphology and gene 
expression pattern of plasma cells reflect their capacity for antibody production and is distinct 
from undifferentiated B cells. The process of plasma cell differentiation depends on both 
induction of a PC specific gene expression programme as well as silencing of the B cell gene 
expression programme. Therefore, the transition of an activated B cell into a plasma cell is 
coordinated and tightly regulated by several key transcription factors. 
Expression of transcription factor paired box protein 5 (Pax5) is essential for development of 
the B cell lineage and the maintenance of B cell identity in mature B cells (Urbánek et al., 1994; 
Horcher et al., 2001). Induction of Pax5 in common lymphoid progenitor cells signifies 
commitment to the B cell lineage, in which it regulates expression of surface receptors that are 
essential to B cell function, such as CD19, CD21, CD23, and Igα. Simultaneously, Pax5 
suppresses genes that are specific to progenitor cells, myeloid cells, T cells, and plasma cells 
(Carotta et al., 2006; Delogu et al., 2006). Even though increased Pax5 levels are associated 
with initial activation of B cells and early events of PC differentiation, efficient terminal PC 
differentiation is linked to Pax5 silencing (Lin et al., 2002; Nera et al., 2006). B cell 
differentiation is regulated in a dose-dependent manner by the transcription factor interferon-
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regulatory factor 4 (IRF4). Low expression of IRF4 in activated B cells induces the germinal 
centre programme via Bcl-6, whereas high expression of IRF4 represses the GC programme 
and instead initiates plasma cell differentiation (Sciammas et al., 2006; Ochiai et al., 2013). 
High expression of IRF4 induces Blimp-1, which directly suppresses Pax5 expression. 
However, initiation of plasma cell differentiation has been shown to be induced upon reduced 
Pax5 levels in a Blimp-1 independent manner (Kallies et al., 2007). Blimp-1 function is crucial 
for terminal differentiation and maintenance of the PC phenotype (Minnich et al., 2016; Tellier 
et al., 2016). The migration of PCs generated in secondary lymphoid organs towards bone 
marrow depends on the expression of CXCR4 and its ligand CXCL12, which is expressed on 
BM stromal cells (Hargreaves et al., 2001). Signaling downstream of CXCR4 needs to be intact 
for terminal differentiation and longevity in the bone marrow niche (Good-Jacobson et al., 
2015; Biajoux et al., 2016). 
 
 
Figure 6. Schematic overview of B cell activation and differentiation. 
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1.5 NF-κB signaling in B cells 
Many of the processes that occur during B cell development require intact signaling of the 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) proteins. Activation of 
the NF-κB pathway can be induced via signaling through the BCR (classical pathway) or via 
signaling through TLRs and cytokine receptors (classical and alternative pathway). 
 
1.5.1 The role of NF-κB in B cells 
The NF-κB signaling pathway has been implicated in several stages of B cell development. 
For instance, NF-κB is required for signaling induced by the pre-BCR, which will prevent 
elimination of pre-B cells expressing functionally rearranged pre-BCRs and thus allows for 
progression to the next developmental stage. Furthermore, NF-κB activity is indispensable for 
survival of immature B cells in the spleen (Franzoso et al., 1997). Studies using mice in which 
NF-κB signaling is compromised have led to increased understanding of the function of 
NF-κB in B cell development. Defects in the classical NF-κB signaling pathway primarily 
affect the development of B-1 and MZB cells, whilst defects in the alternative NF-κB signaling 
pathway disturb the B-2 compartment (Miosge et al., 2002; Pohl et al., 2002; Rauch et al., 
2009; Montecino-Rodriguez and Dorshkind, 2011). Previous studies have identified several 
components required for functional NF-κB activity to be essential for B-1 and MZB cell 
development, such as the IKK, CARD11-Bcl-10-MALT1 (CBM), and LUBAC complexes 
(Egawa et al., 2003; Li et al., 2003; Ruefli-Brasse et al., 2003; Xue et al., 2003; Sasaki et al., 
2013). With the identification of precursor cells that specifically give rise to cells of the B-1 
lineage, it was suggested that the role of NF-κB signaling in the B-1 cell population is restricted 
to their self-renewal capacity (Montecino-Rodriguez et al., 2006; Montecino-Rodriguez and 
Dorshkind, 2011). Nevertheless, as the developmental process of the B-1 lineage and regulation 
thereof through NF-κB activity has not been fully elucidated, future studies are needed to define 
the differential requirements of distinct NF-κB components for development, maintenance and 
survival of B-1 cells. 
 
1.5.2 The NF-κB protein family and regulation of their activity 
The NF-κB protein family comprises five transcription factors: NF-κB1 (p50), NF-κB2 (p52), 
RelA (p65), c-Rel, and RelB. These NF-κB proteins are capable of binding to DNA as various 
combinations of homo- and heterodimers, which determine their binding specificity for 
promotors and enhancers of target genes. RelA, RelB, and c-Rel contain transactivation 
domains (TADs) and are thought to be able to directly induce transcription of their target genes, 
whereas p50 and p52 homodimers are thought to function as repressors due to their lack of 
TADs. 
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NF-κB activity is regulated by inhibitor of NF-κB (IκB) proteins. The classical IκB family 
consists of IκBα, IκBβ, IκBε, and the NF-κB precursor proteins p105 (C-terminus IκBγ), p100 
(C- terminus IκBδ). Classical IκB proteins bind and sequester NF-κB to retain it in an inactive 
state in the cytosol by masking their nuclear localization signals (NLS). These IκB proteins can 
be phosphorylated by the IκB kinase (IKK) complex, resulting in ubiquitination and 
degradation. Consequently, the NF-κB complexes will be released and translocated to the 
nucleus where they can induce or repress transcription of target genes. After translocation into 
the nucleus, the activity of NF-κB dimers is regulated by the atypical nuclear IκB family 
proteins Bcl-3, IκBζ, IκBNS, IκBη and IκBL. Each IκB protein binds with different affinities 
to particular hetero-/ homodimers of NF-κB proteins, thus further increasing the range and 
specificity by which NF-κB regulates its target genes. 
 
1.5.3 IκBNS 
IκBNS was first identified as an inhibitor of NF-κB signaling during negative selection in 
T cells (Fiorini et al., 2002). IκBNS is a protein of 327 amino acids with a molecular weight of 
35 kDa. Similar to other IκB proteins, IκBNS contains seven ankyrin repeat domains, which 
are important for mediating the interaction with NF-κB proteins. IκBNS has been shown to 
interact with p50 and p52 homodimers, which act as inhibitors of NF-κB target genes by 
blocking access to the binding sites, as well as with RelA, RelB, and cRel (Fiorini et al., 2002; 
Touma et al., 2007; Schuster et al., 2012). 
Mice deficient in IκBNS lack the B-1 cell population, have reduced frequencies of MZBs, and 
display impaired responses to TI antigens (Touma et al., 2011; Arnold et al., 2012; Adori et al., 
2018). Apart from a role in B cells, IκBNS is also essential to the development of regulatory 
T cells (Tregs) and the function of CD4
+ effector cells. The transition of precursor Tregs to mature 
Tregs is regulated by IκBNS-induced expression of FoxP3 (Schuster et al., 2012; Schuster et al., 
2017; Schuster et al., 2019). In  CD4+ effector T cells, IκBNS is involved in the proliferation 
and function of TH1, TH17, and TFH cells (Annemann et al., 2015; Hosokawa et al., 2017). 
IL-2, IL-10, IL-17A, IL-17F, and GM-CSF production in TH17 cells depend on IκBNS 
(Annemann et al., 2015). In TFH cells, expression of CXCR5 as well as transcriptional 
regulation of Bcl-6 and IL-21 appear to be mediated by IκBNS (Hosokawa et al., 2017). 
 
Finally, IκBNS is also required for dampening the pro-inflammatory immune response in the 
myeloid lineage. Prolonged p65 activity at the IL-6 promotor has been observed in 
LPS-activated IκBNS-/- macrophages, suggesting that IκBNS is required for the removal 
and/ or degradation of p65 (Kuwata et al., 2006). IκBNS associates predominantly with p50 in 
LPS-activated macrophages, which raises the possibility that alterations in NF-κB activity are 
established through recruitment of IκBNS to NF-κB target genes by p50 (Hirotani et al., 2005). 
Enhanced IL-6 production, as well as IL-12p40 and IL-12p70, was also reported for 
IκBNS-/- DCs (Kuwata et al., 2006). Additionally, TLR-induced IL-10 production in DCs and 
B cells is dependent on IκBNS (Hirotani et al., 2005; Fujita et al., 2006; Miura et al., 2016). 
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1.6 Disorders of the immune system 
Defects in the immune system can result in failure to clear pathogens and (pre)cancerous cells 
and/ or the inability to maintain tolerance towards self-antigens. Depending on whether defects 
are caused by inborn errors or acquired, they are categorised as primary or secondary immune 
disorders. Secondary immunodeficiencies can develop from infections that interfere with 
normal functioning of the immune system, such as acquired immune disorder syndrome 
(AIDS) caused by human immunodeficiency virus (HIV), or from immunosuppressive drugs 
or cancers. Primary immunodeficiencies (PIDs) are caused by mutations in proteins critical to 
the development or function of immune cells, resulting in enhanced susceptibility to infections, 
increased risk of autoimmunity, dysregulated inflammation, and malignancies. 
Common variable immunodeficiencies (CVID) are a heterogenous classification within PIDs 
(Cunningham-Rundles, 2012; Jolles, 2013). CVID patients are typically diagnosed with 
hypogammaglobulinemia, reduced numbers of isotype-switched memory B cells, suffer from 
increased susceptibility towards infections of the respiratory and gastrointestinal tract, and have 
poor vaccine responses (Bonilla et al., 2016). Causative mutations are identified in less than 
20% of CVID patients, with the most common mutations found in genes encoding TACI, ICOS 
and BAFFR, and other proteins required for B cell activation and signaling or interaction with 
T cells (Castigli et al., 2005; Salzer et al., 2005; Bogaert et al., 2016). 
Homo- and heterozygous TACI mutations are associated with 8-10% of CVID cases, but these 
mutations are often also found in healthy individuals, suggesting that additional factors 
contribute to the development of CVID in a subset of individuals harbouring such mutations 
(Martinez-Gallo et al., 2013). 
The application of next-generation sequencing (NGS) methods enabled the identification of 
novel mutations in many other genes now associated with PID and CVID (Maffucci et al., 
2016; Meyts et al., 2016). Mutations in NFKB1 and NFKB2, encoding the NF-κB precursor 
proteins p105 and p100, respectively, have been implicated in the pathogenesis of CVID (Chen 
et al., 2013; Fliegauf et al., 2015; Keller et al., 2017). Additionally, mutations in other 
components of NF-κB signaling, such as CARD11, BCL10 , and MALT1 have also been 
associated with immune dysfunction (Jabara et al., 2013; Stepensky et al., 2013; Torres et al., 
2014). This highlights the importance of intact NF-κB signaling for normal immune function 
as well as the possibility that mutations in other components of the NF-κB pathway potentially 
cause immune disorders. Genetic and phenotypic characterization of novel mutations can 
advance our understanding of the human immune system and CVID pathogenesis. 
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1.7 Animal research models in immunology 
Most, if not all, medical breakthroughs are rooted in scientific discoveries using animal 
research models. The use of animal models is crucial for basic research to increase our 
understanding of fundamental biological processes, as well as for translational and pre-clinical 
research to test the safety and efficacy of pharmaceutical compounds and vaccines before 
approving them for human use. In this thesis, the use of mouse models was essential to the 
research presented in papers I-III with key results forming the basis for the translational work 
presented in paper IV. This chapter provides an overview of the achievements, value, and 
ethics of experimental animal models in biomedical research with a focus on immunology. 
 
1.7.1 The history, rationale and ethics in the use of animal models 
Animals have been used as tools to understand anatomy as early as in the 5th century BC, once 
it was recognised that certain anatomical and physiological functions were preserved between 
humans and animals (Crivellato et al., 2007; Natale et al., 2017; Irschick et al., 2019). The fall 
of the Roman Empire and the subsequent spread of Christian and Islamic ideology halted the 
progress of medical knowledge. The Renaissance caused a renewed interest in the medical field 
which led to an increase in vivisections, autopsies, and experiments on animals (Natale et al., 
2017). Ever since, the scientific use of animal models has greatly contributed to medical 
advancements concerning human health and continues to do so (Fig 7). 
The necessity of using appropriate animal models has been exemplified by the medical tragedy 
caused by thalidomide, a popularly prescribed drug between 1957 and 1962 to treat morning 
sickness in pregnant women, which caused severe birth defects. Before use in humans, 
thalidomide was tested in rabbits and mice, as it was not known at the time that rodents are less 
sensitive to the drug than non-human primates (Merker et al., 1988; Vargesson, 2009). 
The catastrophic outcome of thalidomide usage due to insufficient testing in appropriate animal 
models, resulted in significant improvements in the procedures and legislation of safety testing 
of pharmaceutical drugs and advanced the field of toxicology. Nowadays, the proportion of 
animals used for safety, potency, toxicology, and reproductive studies for pharmaceutical 
substances as required by law comprises 23% of all animals used in research in Europe. 
A comparable number of animals are used in translational and applied research (23%), whereas 
basic research accounts for 48%, and the remainder (9%) is attributed to other purposes such 
as education, monoclonal antibody production, preservation of species, etc. (EC, 2020). 
Naturally, the wellbeing of animals used in research is of great concern. In addition to humane 
treatment, the quality and reproducibility of experimental results obtained from animals are 
influenced by their psychological and physical health (Weed and Raber, 2005). The principles 
known as the 3Rs (replacement, refinement, and reduction) were established in support of 
animal welfare in research settings (Russell and Burch, 1959). In Europe, regulations 
concerning the use, wellbeing, (commercial) breeding, handling, and euthanasia methods of 
research animals are stated in the EU Directive 2010/63/EU, which have been implemented 
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into the Swedish legislation in 2013. Increased ethical awareness and stricter regulation of 
animal research over time, combined with technological advances to create transgenic animal 
models, has shifted the focus of animal research from exploratory to translational and clinical. 
 
1.7.2 The use of animals in immunological studies 
The immune system relies on interaction between many different cell types and their 
environment, and therefore, comprehensive analyses of immune responses require in vivo 
approaches. In vitro cell culture methods do not recapitulate the complexity of the immune 
system, but instead are useful for studying functional properties of immune cells such as their 
growth, activation, and differentiation (in response to cytokines). Many discoveries in 
immunology originate from studies using experimental animal models, such as the 
identification and development of lymphoid organs, haematopoiesis, and the existence and 
function of distinct lymphocyte subsets (Natale et al., 2017). 
The discovery of lymphocytes responsible for antibody production was made in chickens, after 
the observation that removal of the bursa of Fabricius resulted in the inability to generate 
antibodies against Salmonella typhimurium. The bursa of Fabricius, a lymphoid organ in birds 
that is not present in mammals, was later found to be the site where B lymphocytes develop 
and mature (Glick, 1956). The role of the thymus in the production of T lymphocytes was 
recognized a few years later, in studies using mice that were neonatally thymectomized and 
lacked a population of smaller lymphocytes involved in the tolerance regulation of tissue grafts 
(Miller, 1961; Miller, 1962). Considering that mammals lack the bursa of Fabricius, it was 
initially thought that the thymus was required for the development of all mature lymphocytes. 
It was not until the late 60s when bone marrow was identified as the mammalian source of 
antibody producing cells, using cell transfer experiments in irradiated mice (Claman et al., 
1966). In subsequent studies comparing chickens that were either bursectomized or 
thymectomized to chickens were subjected to combined bursectomy and thymectomy, it was 
shown that humoral immunity was facilitated by large lymphocytes originating from the bursa 
of Fabricius, and cellular immunity by smaller lymphocytes originating from the thymus 
(Cooper et al., 1966). Soon thereafter the large and small lymphocytes were renamed as B cells 
and T cells, referring to their organ of origin. 
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1.7.3 Mouse models 
Mice are the commonly used model for addressing functionally relevant questions in 
biomedical research, especially within the field of immunology. Most mouse strains are inbred 
and well characterized, and compared to other species, mice are easy to handle and breed 
rapidly with a gestation period ranging between 19 and 21 days. Nevertheless, results from 
immunological research done in the mouse system are not always translatable to the human 
system due to differences of receptor expression on lymphocytes, differences in function or 
localisation of lymphocytes, susceptibility to pathogens, etc. In order to bridge the gap between 
the mouse models and human immune system, mice can be manipulated in such a way that 
they become more suitable to study human physiology. The transfer of human hematopoietic 
cells into immunodeficient mice to repopulate them with a functional human immune system 
for in vivo studies is an approach that has been in use for more than 30 years (McCune et al., 
1988; Mosier et al., 1988). Depending on the nature and potential of the cells used for transfer, 
the human immune system can be reconstituted partially or almost completely (Lan et al., 2006; 
Chung et al., 2015). SCID/NOD IL2Rγnull mice receiving human bone, thymus, and spleen 
transplants followed by transfer of foetal liver cells, so far seem to harbour the most accurate 
representation of a human immune system in mice (Chung et al., 2015). 
More recent technological advances are focused on generating knock-in mouse strains in which 
human genes of interest are inserted into the mouse genome. For example, genes encoding the 
human immunoglobulin variable regions were inserted in the corresponding murine loci, 
generating mice that express antibodies of which the variable region is human and the constant 
region murine (Lee et al., 2014; Murphy et al., 2014). These transgenic humanised mice are 
used for the generation of antibodies for therapeutic purposes and studies of antibody responses 
against human pathogens. A major caveat of this system is that the expressed BCR repertoire 
in these mice are restricted to the immunoglobulin alleles of one human individual and is not 
representative of immunoglobulin diversity observed in the human population. 
Another approach is to introduce targeted mutations, inserts, deletions, or recombinations that 
were identified in patients into the mouse genome to create transgenic mice. This way, genes 
of interest can be manipulated to recapitulate human disease and allow for mechanistic studies 
and development of therapeutics in vivo (Walsh et al., 2017; Lampreht Tratar et al., 2018). 
Nevertheless, the general concern for humanised and transgenic animals remains that cytokine 
and cytokine receptor expression, distribution and function differ between human and murine 
immune cells. Discrepancies between different model systems can result in an artificial 
environment with many confounding factors and should be taken into consideration when 
interpreting results obtained from studies using modified animals. 
 
1.7.4 Other animal models in immunology 
Despite their versatility and ease of use, mice are not always a suitable model for the human 
immune system. Apart from differences in immune cells, other limitations of mice models are 
 18 
decreased or no susceptibility to many human diseases and the volume of tissues that can be 
sampled. For studies focusing on pathogenicity, the susceptibility of the animal model to the 
pathogen has to be taken into consideration. Other rodents commonly used in immunology are 
rats, guinea pigs, and rabbits1. In the case of influenza and other droplet/aerosol-transmitted 
infections, ferrets are the model of preference, because the physiology of their respiratory tract 
is similar to humans, they are naturally susceptible to most human respiratory viruses, and they 
resolve the infection in a manner similar to humans (Belser et al., 2011). 
For preclinical studies of pharmaceutical substances and vaccine development, often non-
human primates (NHPs) are used due to the high degree of similarity with humans with regards 
to physiology, immunocompetence, and susceptibility to pathogens (Bluemel et al., 2015; Estes 
et al., 2018). The use of NHPs in vaccine immunology has tremendously increased since the 
1950s, due to the realisation that certain therapeutics can act in a species-specific manner as 
well as major efforts to develop effective vaccines, for example the successful polio vaccines 
(Salk, 1956; Sabin, 1957; Merker et al., 1988). The identification of HIV-1 in 1983 as a novel 
human pathogen with the potential to cause serious disease further standardized the use of 
NHPs as a valuable model for human infections and vaccine design, even though only 
chimpanzees were found to be naturally susceptible to HIV-1 (Estes et al., 2018). The 
subsequent discovery of simian immunodeficiency virus (SIV), which caused disease in rhesus 
macaques that were housed with other species of NHPs, led to the creation of chimeric 
HIV/SIV viruses. These became the led  preferred models for studies on AIDS, development 
of retroviral therapeutics, and vaccine design (Letvin et al., 1983; Chahroudi et al., 2012; Estes 
et al., 2018). 
 
1.7.5 Studies on human research subjects 
Ultimately, the most suitable model in which to study human pathogens and disease 
mechanisms, is the human system itself. Collection of cells or tissues from healthy volunteers 
and patients is useful for immediate analysis and in vitro studies. Some human tissues can be 
modelled in vitro by 3D culturing to achieve a cellular organisation similar to in vivo tissue 
structures (Fang and Eglen, 2017). Even though the application of 3D tissue culturing is limited 
to the cell types that can be generated through in vitro cultures of human induced pluripotent 
stem cells (HiPSCs), it has been a promising development for the fields of oncology, neurology, 
cardiology, and ophthalmology (Eglen and Reisine, 2019). For immunology and vaccine 
studies, in vivo studies remain the most suitable approach for understanding protective immune 
responses. Some in vivo studies require exposure of study subjects to pathogens, such as 
evaluation of malaria vaccine efficiency under controlled human malaria infection (CHMI) and 
influenza challenge studies in the interest of universal influenza vaccine design and 
development of novel antiviral therapeutics (Roestenberg et al., 2011; Sherman et al., 2019). 
 
1 Whether guinea pigs (Caviomorpha) and rabbits (Lagomorpha) should be defined as rodents is disputed. 
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The current COVID-19 pandemic has led to the proposal of human challenge studies with 
SARS-CoV-2 to improve and accelerate vaccine design (Eyal et al., 2020; Plotkin and Caplan, 
2020). This has been perceived as controversial due to the potential risks to study participants, 
spread to third parties, and incomplete understanding of COVID-19 pathogenesis. 
Most analyses from human studies rely on non-invasive sampling of peripheral blood, from 
which antibody responses, cytokines, and lymphocytes can be analysed. However, some 
fundamental processes, such as cellular interactions, such as germinal centre formation, are not 
detectible from blood samples. As these processes take place in secondary lymphoid organs, 
fine needle aspirations to collect cells from draining lymph nodes could be considered as a low-
invasive method for tissue sampling (de Hair et al., 2012; Tatovic et al., 2015). Considering the 
ethics involved in human experimentation, clinical trials and in vivo studies using human 
subjects require ethical approval from an independent review board and informed written 
consent from subjects. 
 
 
Figure 7. Medical interventions developed using experimental animal models and the advances made in 
translation to human relevance. Early experimental work often used non-anaesthetised animals to gain 
knowledge on organ and tissue function, or to practice and refine operational approaches before applying them 
to human subjects. Rodents became popular since the 1650s when the renaissance caused a surge in scientific 
discoveries. Attempts to formulate vaccines that are safe and efficient for human use, introduced non-human 
primates, which are still valuable in pre-clinical models. The process of humanising mice dates back to 1988, 
when the first successful cell grafts were done in immunodeficient mice. Currently, generation of gene-targeted 
engineered mice are a popular method for understanding human pathogenesis and immune responses. 
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1.7.6 Brief history of human research ethics 
The earliest collection of medical literature dates back to the 5th century BC and includes an 
oath of ethics which is still symbolically taken by physicians as of today: the Hippocratic Oath. 
This includes several ethical principles that have remained relevant in modern-day society, 
such as medical confidentiality and using medical knowledge to help and not to harm. 
Unfortunately, human history knows many examples of unethical research on human subjects. 
For example, the Tuskegee syphilis experiment was meant to study the natural course of 
syphilis infection in African American males between 1932 and 1971. Subjects were coerced 
into participation, withheld information, and deprived of treatment, despite the proven 
effectiveness of penicillin by 1942 (Brandt, 1978). Furthermore, studies on the pathogenesis 
and treatment of infectious diseases (incl. malaria, typhus, tuberculosis, yellow fever, hepatitis) 
and organ transplantations were part of the human experiments of horrifying nature that were 
conducted during the Nazi regime in concentration camps during 1939-1945 (Weindling et al., 
2016). Twins, often children, were used for the sole purpose of using one as an experimental 
subject and the other as a genetic control (Weindling et al., 2016). 
The inhumane experimentation came to light during the Nuremberg trials and resulted in 
prosecution of the responsible physicians and simultaneously in the establishment of the 
Nuremberg code in 1947. The Nuremberg code explicitly states informed consent as a 
prerequisite for inclusion of individuals in human experiments, and strongly emphasizes that 
studies should be designed to protect the wellbeing of participants. 
Nowadays, the ethical principles that human experimentation should adhere to are similar in 
nature to the Hippocratic Oath and the Nuremberg Code, and are stated in the Declaration of 
Helsinki 1964 with the most recent amendment made in 2013. The Declaration emphasizes 
principles that are at the core of ethical medical research, e.g. the duty of physicians to act in 
their patient’s best interest, confidentiality of patient data, independent reviews of the ethical 
standards of human experiments, and replacement by animal models or in vitro models 
whenever possible (WMA, 2018). 
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2 AIMS OF THIS THESIS 
 
The overall aim of this thesis was to characterize the role of IκBNS in B cell development and 
antibody responses. The individual aims were as follows: 
 
Paper I: To investigate the requirement of IκBNS in the development of B-1a cells. 
Paper II: To evaluate TACI functionality and plasma cell differentiation as underlying 
mechanisms of defective T cell-independent responses caused by the absence of IκBNS. 
Paper III: To determine the requirement for IκBNS in T cell dependent humoral responses 
using a B cell conditional knock-out mouse model. 
Paper IV: To establish robust in vitro assays for the analysis of human plasma cell 
differentiation. 
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3 METHODOLOGICAL CONSIDERATIONS 
 
Choosing the most suitable animal model to address a certain research question is crucial, as is 
designing experimental set-ups using the appropriate methods and conditions. This chapter 
describes general considerations regarding experimental approaches and selected methods. 
More detailed information regarding methods and experimental protocols can be found in the 
material and methods sections of respective papers. 
 
3.1 Ethical considerations 
All mice experiments were planned and performed according to institutional guidelines and 
with approval of the Committee for Animal Ethics (Stockholms Norra Djursförsöksetiska 
nämnd, ethical permit no. N521/12 for paper I and N4/16 for paper II and III). To ensure 
animal welfare, we followed the 3R guidelines of replacement, refinement, and reduction 
(Russell and Burch, 1959). We evaluated the level of discomfort caused by immunization or 
experimental approaches in the mice beforehand and monitored the wellbeing of the mice 
during experiments when necessary. For example, when analyzing plasma cell generation in 
vivo in paper II, we observed a significant reduction of discomfort in our mice when reducing 
the injected dose of LPS from 10 µg to 5 µg. In addition, considering the distress caused by 
alum adjuvants in mice, we decided to use  AddaVaxTM as an adjuvant for the NP-CGG 
immunizations in paper III (Conrad et al., 2009). For paper IV, no ethical permits were 
required as all experiments were carried out using anonymized blood donor samples. 
 
3.2 Mouse models 
In this thesis, we studied the role of the protein IκBNS in B cells using mouse strains with 
genetic alterations in the nfkbid gene. IκBNS-deficient bumble mice were used in paper I-III.  
The bumble strain was generated and identified in the Beutler lab through ENU-mutagenesis 
and a screen for mice that displayed defects in antibody production following immunization 
(Arnold et al., 2012) (Fig. 8). 
 
Figure 8. An overview of the forward genetic screen using 
ENU-mutagenesis in the Beutler lab. Male C57BL/6 mice were 
injected with ENU and bred until the 3rd generation to ascertain 
mutations were genetically transferrable. G3 mice were 
immunised with rSFV-βGal at day 0, NP-Ficoll at day 10, and at 
day 14 antigen-specific antibody responses were evaluated. 
Sequencing was performed on mice with defective responses to 
identify causative ENU-induced mutations. 
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Considering that IκBNS also affects the development and function of other immune cells, such 
as macrophages, dendritic cells, regulatory T cells and Th17 cells (Kuwata et al., 2006; 
Schuster et al., 2012; Annemann et al., 2015), the bumble strain is less suitable for studying 
alterations in TD responses as defects in the T cell compartment cannot be ruled out. Therefore, 
we generated a mouse strain with a B cell specific deletion of IκBNS using the Cre-loxP system 
in paper III. Our first effort of generating B cell conditional IκBNS knock-out mice utilized 
the Cd19Cre strain. Early phenotypic characterisation of Cd19Cre/+nfkbidfl/fl mice revealed 
variable frequencies of B-1a cells (unpublished data), suggesting inefficient or excision of 
nfkbid alleles too late during development. We then generated B cell conditional IκBNS knock-
out mice using the Cd79aCre strain, since Cd79a is expressed prior to Cd19 during B cell 
development and has been shown to be more efficient in Cre-mediated excision of target genes 
(Hobeika et al., 2006) (Fig. 9). 
 
 
 
Figure 9. Generation of the Cd79aCre/+nfkbidfl/fl strain. (A) To remove the lacZ and neo cassette from the nfkbid 
locus, nfkbidtm1a mice were crossed to FLPe knock-in ROSA26Fki mice in the Beutler lab, creating nfkbidtm1c 
(nfkbidfl/fl) mice which were shipped to the GHK group. Nfkbidfl/fl mice were crossed to Cd79aCre/+ mice (1st cross), 
Cd79aCre/+nfkbidfl/WT mice (2nd cross), and Cd79aCre/+ nfkbidfl/fl (3rd cross). As both the Cd79a gene and the nfkbid 
gene are located on chromosome 7, the 3rd cross was dependent on a chromosomal crossover event. Highlights 
indicate breeding stage where Flp-mediated FRT recombination (green) and Cre-mediated loxP recombination 
(red) occur. (B) Flp recombinase-mediated excision of the lacZ and neo cassettes to generate nfkbidtm1c alleles 
(upper panel) and Cre recombinase-mediated excision of coding exons 4 to 8 of the nfkbid allele to generate 
nfkbidtm1d alleles in nfkbidB- mice (lower panel). 
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During the breeding and crossing process, genotyping was performed on ear biopsies of 
weaned mice to detect Cd79a wildtype alleles, the Cre sequence, and loxP regions in the nfkbid 
alleles. B cell conditional knock-out mice with the Cd79aCre/+ nfkbidfl/fl genotype were named 
IκBNSB- and their littermate controls with the Cd79a+/+ nfkbidfl/fl genotype were named 
IκBNSB+. B-1a cell frequencies from the peritoneal cavities of IκBNSB- mice in paper III were 
evaluated as an indirect assessment of the loss of functional IκBNS, as in paper I it was shown 
that the loss of B-1a cells is an intrinsic defect. To verify the deletion of the nfkbid alleles in 
IκBNSB- mice, we assessed nfkbid RNA levels by real-time PCR on isolated B cells that had 
been stimulated for 2 hours with anti-IgM. The strain was maintained by breeding nfkbidB+ 
mice to nfkbidB- mice to preserve the Cd79aCre allele in a hemizygous state. 
 
3.3 Immunizations 
For studying humoral responses towards TI antigens, we used the model antigens TNP-LPS in 
paper I, LPS in paper II, and NP-Ficoll in papers I, II and III. LPS (a TI-1 antigen) is a 
potent activator of murine B cells with the advantage that it can be used to immunise mice in 
vivo and to stimulate isolated B cells in vitro, thus allowing us to evaluate plasma cell 
differentiation under both conditions in response to the same antigen. The use of the hapten 
(4-hydroxy-3-nitrophenyl)acetyl (NP) makes it possible to evaluate antibody affinity, since, for 
antibody detection, NP molecules can be coupled to BSA at different densities. 
For studying humoral responses towards TD antigens in paper III, we used the model antigens 
NP-CGG in AddaVaxTM and rSFV-βGal. NP conjugated to the T cell antigen chicken γ-
globulin has been in use for several decades to study immune responses in mice. AddaVaxTM 
is an oil-in-water based adjuvant similar to MF59®, which is used in various human vaccines 
and induces both Th1 and Th2 immune responses (Ott et al., 1995). 
We had previously observed delayed GC responses in bumble (unpublished data) and therefore, 
to accurately follow the dynamics of the GC response over time, we evaluated the immune 
response to NP-CGG at 7, 14 and 21 days. rSFV-βGal is a Semliki Forest Virus-based vector 
encoding the model antigen β-Galactosidase (Smerdou and Liljeström, 1999). Recombinant 
Semliki Forest Virus (rSFV) particles were produced using a trans-replication system that 
prevents genes encoding viral structural proteins from being packaged into newly synthesized 
particles. As a result, rSFV particles are replication incompetent and only able to cause a single 
round of infection in cells (Smerdou and Liljeström, 1999). 
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3.4 Sample processing and cell isolations 
To study functional properties of B cells, we performed in vitro culture experiments using 
primary cells isolated from the spleen (for mouse studies) or blood (for human studies). Murine 
tissues and organs were homogenised through a cell strainer to obtain single cell suspensions 
and, in case of spleen and blood samples, treated with red blood cell lysis buffer to deplete 
erythrocytes. Foetal liver cells were prepared using Lymphoprep in paper I. 
Density gradient separation with Ficoll-Paque was used for human blood to isolate PBMCs in 
paper IV (Fig. 10). 
The composition of cells within the PBMC fraction varies on an individual basis, but usually 
consists of 70-90% leukocytes, 10-20% monocytes, and 1-2% dendritic cells. Within the 
lymphocyte population, 70-85% consists of T cells, 5-10% of B cells, and 5-20% of NK cells 
(Kleiveland, 2015). For isolation of murine and human B cells, we used EasySep isolation kits 
as these allow for enrichment of cells within 20 minutes with high yield and purity. 
Furthermore, we used negative selection kits to avoid unintentional activation of cells by 
antibody-binding.  
 
 
 
 
Figure 10. Separation of PBMCs using Ficoll-Paque density gradient centrifugation. Blood is diluted in PBS 
and carefully layered on top of 10ml Ficoll-Paque. The density of Ficoll-Paque is 1.077 g/mL and during 
centrifugation cells with a higher density (erythrocytes and granulocytes) are able to migrate through Ficoll-
Paque and sediment at the bottom of the tube. Mononuclear cells of the lymphoid and myeloid lineage have a 
lower density than Ficoll-Paque and thus remain in the upper fraction. 
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3.5 In vitro B cell stimulations 
Cells were stimulated in vitro with LPS to model TI-1 antigen and anti-IgM to model TI-2 
antigen activation in paper II. For read-outs on plasma cell differentiation, cells were cultured 
with LPS, as anti-IgM alone is not sufficient for survival and differentiation of cells. 
To induce nfkbid mRNA expression in paper III, we cultured cells for 2 hours with anti-IgM 
as we previously observed the highest expression levels at this timepoint (unpublished data).  
For paper IV, the stimulations chosen were based on B cell activating antigens and cytokines 
that are known to induce plasma cell differentiation. Stimulation I and II had been optimised 
previously within our group for differentiation of macaque memory B cells into antibody 
secreting cells (Sundling et al., 2010), stimulation III was selected based on its ability to induce 
Blimp-1 expression (Banko et al., 2017), and stimulation IV was selected as it potently induced 
plasma cell differentiation in vitro (Le Gallou et al., 2012). We did not consider differentiation 
protocols requiring long-term cultures and multiple media replenishments, as the objective for 
this paper was to establish a robust and efficient yet simple method suitable for application in 
the clinic. 
 
3.6 Evaluation of cell populations by flow cytometry and FACS 
Flow cytometry is a well-established method for the detection, measurement and isolation of 
cell populations. Cells are stained with fluorescently labelled antibodies and then acquired in 
suspension on a flow cytometer, which uses lasers to excite the fluorophores and detectors to 
record the intensity of fluorescence emitted. This technique allows for the identification, 
quantification and phenotyping of cells. However, because single cells are analysed in 
suspension, information regarding tissue structure, cellular distribution, and intercellular 
interaction is lost. We have used flow cytometry in this thesis for the identification and 
quantification of distinct subsets of B cell populations, and the activation and differentiation 
status of cells after in vitro stimulation or in vivo immunization. 
 
 
 
Figure 11. Evaluating cellular proliferation by flow cytometry. 
Cells are labelled with CTV, stimulated, and allowed to proliferate in 
vitro. During each division, the dye is distributed equally over the two 
daughter cells. This results in a sequential decrease in fluorescence that 
is proportional to the number of divisions that a cell has undergone. 
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In papers II and IV we used flow cytometry to assess proliferation of cells using the 
CellTraceTM Violet dye (CTV) (Fig. 11). In contrast to murine cells, primary human B cells 
were more prone to cell death during CTV labelling, most likely due to DMSO exposure, and 
we optimised the concentration to 0.25 µM instead of the 1 µM dose used for murine cells. For 
intracellular Blimp-1 stains in paper IV, incubation of cells with the Blimp-1 antibody required 
6 hours for the signal to be detectable. 
A major advantage of flow cytometry is the possibility of sorting out cell populations for 
downstream applications. We have used flow cytometry sorts in paper I to purify transitional 
B cell populations (CD93+IgM+, CD93+IgM+CD5-, and CD93+IgM+CD5+ cells) for cell 
transfer experiments, and in paper II to purify follicular B cells (L/D-B220+CD21loCD23hi) for 
in vitro cultures.  
 
3.7 Detection of antibodies by ELISA 
Immunoassays are based on the principle of detecting antigens through binding by antigen-
specific antibodies that are labelled with a detectable component. The earliest immunoassays 
were developed during the 1950s and used radioactive isotopes (Yalow and Berson, 1960). 
Conjugation of antibodies to enzymes, such as alkaline phosphatase (ALP) and horseradish 
peroxidase (HRP), popularised and standardized the use of immunoassays (Engvall and 
Perlmann, 1971; Van Weemen and Schuurs, 1971). 
Enzyme-linked immunosorbent assay (ELISA) is a method that allows for both quantitative 
and qualitative measurement of proteins of interest, such as antigens, antibodies, or cytokines. 
ELISA measurements are sensitive and commonly used to determine the concentration of 
antibodies in samples. However, it is not possible to identify the cells that produced and 
secreted the antibodies. The general principle of ELISA is to capture the protein of interest on 
wells pre-coated with primary antibody, detect the captured protein by a secondary antibody 
conjugated to an enzyme, and then add substrate which is converted into coloured product that 
can be measured. 
The ELISA methods used in this thesis were developed to detect the presence of natural 
antibodies in papers I and III, antibodies produced upon in vitro stimulation in paper II and 
IV, and antigen-specific antibodies induced by immunization in paper I, II and III. 
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3.8 Detection of antibody-producing cells by ELISpot 
Enzyme-linked immunosorbent spot (ELISpot) assays enable the quantification of cells that 
are producing proteins of interests, such as antibodies or cytokines. This method was developed 
in the 1980s and replaced the plaque-forming assay that was based on haemolysis of sheep red 
blood cells (SRBCs) for the detection of IgM-producing cells (Czerkinsky et al., 1983). 
Cells are seeded in wells that have been pre-coated with antibodies specific for the protein of 
interest, so that the proteins are bound on the spot where they are produced by a cell. 
A secondary antibody conjugated to an enzyme is allowed to bind to the proteins, and 
development of the assay is done by adding substrate that, once converted by the enzyme, 
visually marks the spot where the protein has been produced by the cell. The number of spots 
in a well is used to determine the numbers of cells capable of producing the protein of interest, 
while the size of the spot is indicative of the amount of protein produced by an individual cell.  
We have used ELISpot in paper I to detect and enumerate IgM producing cells. 
 
3.9 Statistics 
We applied two-tailed unpaired t-test in paper I and II to detect differences in the mean values 
measured between samples. In paper II we also used Mann-Whitney U-test for data sets that 
showed unequal distributions between samples. To account for differences in variations caused 
by mouse strain backgrounds in paper III, we applied the Student’s t-test with Welch’s 
correction, which is more reliable in cases of unequal variation and unequal sample sizes 
between tested groups. Biological variation in humans is far greater than in laboratory mouse 
strains that have been inbred to the extent of being genetically identical, and therefore, in paper 
IV, we used the Mann-Whitney U-test that tests the hypothesis of equal/ unequal distribution 
and is less sensitive to skewed data sets with outliers compared to the unpaired Student’s t-test.
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4 RESULTS AND DISCUSSION 
Our studies have focussed on a nuclear regulator of the NF-κB pathway, IκBNS, which was 
originally identified 18 years ago (Fiorini et al., 2002). IκBNS is presumed to have an inhibitory 
function in the myeloid lineage in response to LPS as IκBNS KO macrophages and dendritic 
cells exhibit increased production of pro-inflammatory cytokines (Kuwata et al., 2006). In 
contrast, in the lymphoid lineage IκBNS has been shown to play a role in the development, 
proliferation and function of B cells and T cells (Touma et al., 2011; Arnold et al., 2012; 
Schuster et al., 2012; Annemann et al., 2015). The work included in this thesis focuses on the 
role of IκBNS in B cell development and function, as well as the development of methods to 
evaluate PC differentiation of human primary B cells. In this chapter, the main findings of 
papers I-IV and relevant unpublished data are presented and discussed. 
 
4.1 The absence of B-1a cells in bumble is an intrinsic 
developmental defect 
Bumble mice were identified in an ENU-mutagenesis screen based on their impaired antibody 
responses towards NP-Ficoll and rSFV-βGal. The causative mutation was mapped to the fourth 
intron of the nfkbid gene, causing a T→G transversion in the splice region preventing the 
removal of this intron in mRNA transcripts. The stop codon present in this intron presumably 
terminates transcription after 65 of the 327 aa full-length IκBNS protein. Examination of the 
lymphocyte compartment in the bumble mice revealed a severely reduced B-1 cell population 
in addition to the impaired humoral responses (Arnold et al., 2012). 
To understand the role(s) of IκBNS in B-1a cells, we examined B-1 cell development and TI 
responses in bumble in paper I. Development of the B-1 lineage begins in the foetus, with the 
foetal liver playing a prominent role in the expansion of B-1 progenitor (B-1p) cells, whereas 
after birth, the neonatal spleen is the main location for transitional B cells to mature, after which 
they migrate and take residency in the peritoneal and pleural cavities. 
First, we showed that B-1a cells were completely lacking and B-1b cells were severely reduced 
in the peritoneal cavity of bumble mice (Fig. 12A). In addition, we found no B-1a cells and 
reduced B-1b cells in the spleen and bone marrow, rendering it unlikely that the B-1 cell 
population was lacking in these tissues due to defects in migration. Next, we transferred 
wildtype B-1 cells into bumble mice and observed an expansion of donor B-1 cells in the 
peritoneum and in the spleen. Thus, possible defects in microenvironment were also excluded 
as a possible cause for the lack of B-1 cells in bumble. 
In contrast to cells of the B-2 lineage, B-1 cells are not continuously generated from bone 
marrow, but instead rely on self-renewal to preserve the B-1 pool throughout life. We therefore 
evaluated B-1a cell frequencies at different intervals between 1 and 16 weeks of age, as a loss 
of these populations over time would indicate a limited potential of self-renewal. Whilst we 
were able to detect an increase of peritoneal B-1a cells from week 1 to 5 followed by sustained 
 32 
frequencies in wildtype, no B-1a cells were detected in bumble at any time point. Similarly, in 
wildtype mice we observed a pronounced population of B-1a cells in the spleen already at 
week 1 but not in bumble. Given the absence of B-1a cells at all time points, we concluded that 
rather than a defect in self-renewal, it was more likely a defect in B-1a cell development that 
caused the bumble phenotype. Moreover, chimera studies revealed that the inability of bumble 
foetal liver and bone marrow cells to generate B-1a cells was cell-intrinsic, as the presence of 
wildtype cells did not restore their ability to develop into B-1a cells. 
 
4.2 B-1a cells develop via a transitional B-1a cell stage which is 
missing in bumble 
In order to identify at which developmental stage IκBNS is required for the generation of B-1 
cells, we examined the frequencies of progenitor cells known for their capacity to give rise to 
the B-1 lineage. We found normal frequencies of Lin-CD93+CD19+B220lo/-  B-1p in foetal liver 
at E15 as well as of IgM+CD93+ splenic TrB cells at week 1 in bumble, suggesting that IκBNS 
is not required for B-1 cell development until after the transitional B cell stage. Upon further 
examination of the TrB cells, we could distinguish two phenotypically distinct populations of 
B220loCD5+ and B220+CD5- cells. However, of these two populations, the transitional 
B220loCD5+ cells were not present in bumble. 
Transfer experiments of wildtype cells of each population into bumble mice demonstrated the 
capacity of CD5+ TrB cells to give rise to mature B-1a cells, whereas CD5- TrB gave rise to 
both the B-1 and B-2 lineage (Fig. 12B). Hence, we named the B220loCD5+ subpopulation 
transitional B-1a (TrB-1a). Considering their potential for B-1a cell generation, we sought to 
identify more evidence of their commitment to the B-1 lineage. We found the TrB-1a 
population to express CD43, exhibit increased λ light chain usage, and naturally secrete IgM, 
all of which are considered features of mature B-1a cells. 
A reduction in B-1 cells has also been observed in mice deficient in components of the classical 
NF-κB pathway, such as p50, the CARD11-Bcl-10-MALT1 complex, the IKK complex, and 
the LUBAC complex (Pohl et al., 2002; Egawa et al., 2003; Hara et al., 2003; Li et al., 2003; 
Xue et al., 2003). Intact frequencies of neonatal TrB cells in these mice can incorrectly lead to 
the assumption that signaling through the classical NF-κB pathway is essential to the survival 
and maintenance of B-1a cells instead of their generation. Therefore, identification of the 
intermediate TrB-1a stage can help determine developmental defects caused by other NF-κB 
components in the classical and alternative pathway. 
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Unlike B-1a cells, which were completely absent, B-1b cells were detectable in bumble, albeit 
at reduced frequencies compared to wildtype. Differential requirements for the development of 
B-1b cells are not well studied. Our data indicated that B-1b cells were generated from both 
CD5+ and CD5- TrB cells. Therefore, it might be possible that in bumble B-1b cell generation 
from CD5- TrB cell population is intact and that their reduced frequencies reflect the loss of B-
1b cells derived from the CD5+ TrB population. 
 
4.3 Impaired TI responses in the absence of IκBNS 
Clearance of TI antigens is predominantly facilitated by B-1 cells and MZBs. In paper I, we 
showed that bumble mice do not produce NP-specific IgM or IgG responses to NP-Ficoll, and 
no IgM to TNP-LPS. Transfer of wildtype peritoneal cells to bumble partially restored NP-
Ficoll responses, suggesting that the lack of B-1 cell contributes to the observed impairment in 
TI responses (Fig. 12C). In a follow-up study not included in this thesis, we demonstrated that 
in mice heterozygous for the bumble mutation, the B-1 cell compartment was intact yet 
antibody responses towards NP-Ficoll and Pneumovax were attenuated (Pedersen et al., 2016). 
Taken together, these results indicated that the impaired TI responses observed in bumble are 
due to the lack of B-1a cells as well as defects in B cell function. NP-Ficoll induced antibody 
titres were also undetectable in nfkbidB- mice, in which IκBNS is selectively deleted from the 
B cell compartment, further strengthening the notion that the impaired TI response is intrinsic. 
 
Figure 12. Overview of key findings in 
paper I. (A) CD19+B220loCD43+CD5+ B-1a 
cells and CD19+B220loCD43+CD5- B-1b 
cells are absent in the peritoneal cavity of 
bumble mice. (B) Wildtype neonatal 
IgM+CD93+CD5+ and IgM+CD93+CD5- 
transitional B cells were sorted and 
transferred into bumble mice to investigate 
their potential to give rise to the mature B-
1a, B-1b and B-2 lineages. Donor cells were 
analysed 4-6 days post-transfer. CD5+ TrB 
predominantly generated B-1a cells whilst 
CD5- TrB were more efficient in generating 
B-2 cells. (C) Transfer of wildtype B-1a cells 
into bumble mice partially restored the 
antibody response upon immunization with 
the TI-2 antigen NP-Ficoll. 
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4.4 Bumble displays lower Igλ usage in all B cell subsets 
B-1a and MZB cells in B6 mice have been reported to exhibit an increased proportion of Igλ 
usage compared to the FOB cell population, which consists of Igκ+ cells and Igλ+ cells in a 95 
to 5 ratio (Hayakawa et al., 1986; Arakawa et al., 1996; Carey et al., 2008). Igκ rearrangement 
occurs prior to Igλ rearrangement, and prolonged survival mediated through NF-κB signaling 
seems to be required for Igλ rearrangement but not Igκ rearrangement (Derudder et al., 2016).  
To support our finding that increased immunoglobulin light chain usage is an indication of 
early B cell lineage predisposition in the TrB cell population, we determined the frequencies 
of Igκ+ and Igλ+ cells in the mature B cell subsets and expanded our analysis to bumble B cells. 
Examination of the light chain usage in wildtype subsets confirmed previous findings that the 
B-1 cell population contains a higher proportion of Igλ+ cells than the B-2 cell population and 
revealed a modest increase of Igλ usage in the MZB cell subset compared to the FOB cell 
subset. As may be expected from the lack of B-1a cells in bumble, the peritoneal B-1 population 
exhibited decreased Igλ usage (Fig. 13). The CD19+B220lo bumble cells that were detectable 
might be a heterogeneous population consisting of B-1b and immature B cells. The possibility 
remains that bumble B-1b cells are affected in their capacity to generate Igλ+ cells. When 
comparing the B-2 cell population, bumble B-2 cells displayed reduced levels of Igλ usage 
compared to wildtype B-2 cells in the peritoneal cavity but not in the spleen (Fig. 13). 
To examine Igλ usage in the FOB and MZB population, we used 5 months old mice as MZBs 
are initially reduced but increase in frequency upon aging. Again, we found decreased Igλ 
usage in bumble in both subsets (Fig. 13). As alterations in the Igκ+ to Igλ+ cell ratio extended 
beyond the B-1 lineage in bumble, these results suggest that disturbed Igλ usage results from a 
general impairment in the absence of IκBNS. Considering that overexpression of pro-survival 
signals such as Bcl-2 restored Igλ usage in mice deficient for NEMO and IKK1/IKK2, it would 
be worthwhile investigating whether IκBNS-dependent NF-κB activity is necessary in 
mediating survival signals. Alternatively, IκBNS could be involved in Igλ locus accessibility, 
as Vλ and Jλ germline gene segments were more efficiently transcribed upon IκBα-mediated 
NF-κB activity (Bendall et al., 2001). 
Interestingly, activation causes bumble B cells to rapidly upregulate Blimp-1 (see section 4.6)  
and recent data indicate that Blimp-1 limits the repertoire of autoreactive B-1a cells presumably 
via repression of the anti-apoptotic protein Bcl-2 (Hug et al., 2014; Setz et al., 2018). Pre-BCR 
signaling induces IRF4 expression, which facilitates RAG-mediated light chain recombination 
in pre-B cells in favour of Igλ recombination and independently of IL-7 (Johnson et al., 2008). 
It has been suggested that high IRF4 levels potentially induce Blimp-1 in pre-B cells, which 
then interfere with proliferation and survival of autoreactive cells. As B-1 cells are known to 
be selected on self-antigen, this could be a mechanism to deplete autoreactive cells that are 
harmful. 
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Figure 13. Igλ to Igκ ratio is reduced in the absence of IκBNS (unpublished data). (A) Gating strategy for 
examining Igκ and Igλ usage in peritoneal CD19+B220lo B-1 and CD19+B220+ B-2 cells (upper panel) and splenic 
B220+CD21loCD23+ FOB and B220+CD21+CD23lo MZB cells (lower panel). Numbers denote frequencies of 
gated populations. (B) Bar graphs show the ratio of Igλ to Igκ expressing cells within the peritoneal B-1 and B-2 
population (upper panel) and splenic B-1 and B-2 population (middle panel) in 8 week old mice, and splenic FOB 
and MZB population (lower panel) in 5 month old mice. Statistical differences were determined using the Student’s 
t-test and indicated by ns (not significant) and *** (p<0.001). Splenic B-1 cells were not detected (ND) in bumble. 
 
In light of the rapid Blimp-1 expression observed during PC differentiation in bumble B cells, 
it is plausible that during B cell development Blimp-1 is disproportionally expressed in 
progenitor cells of the B-1 lineage and triggers cell death through Bcl-2 repression. 
The transitional window in which IκBNS is required, e.g. between the B-1p and TrB-1a stage, 
coincides with surface expression of IgM. Thus, BCR-induced negative selection mediated via 
elevated IRF4/ Blimp-1 expression would correspond to the developmental time point at which 
cells with B-1a potential are lost in bumble. Future studies using Blimp-1 repression and/ or 
Bcl-2 overexpression in bumble to verify whether B-1a and Igλ+ cells generation can be 
rescued, could help elucidate the underlying mechanism that causes the loss of B-1a cells. 
 
4.5 TACI expression and function is dependent on IκBNS 
The absence of antibody production towards TI antigens in bumble mice made us question 
whether bumble B cells were able to generate ASCs at all. In paper II, we demonstrate that, 
despite relatively normal early activation, LPS-induced PB and PC populations were strongly 
reduced in bumble mice (Fig. 15A). Similar to bumble, XID mice that are deficient in Bruton’s 
tyrosine kinase (Btk) are also unresponsive to TI-2 antigens. This has been linked to reduced 
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expression of the surface protein TACI, which could be partially rescued through CpG 
stimulation (Uslu et al., 2014). Studies using TACI-/- mice have established TACI as an 
important surface receptor involved in the generation antibody responses towards both TI-1 
and TI-2 antigens (von Bülow et al., 2001; Yan et al., 2001; Mantchev et al., 2007). In TACI-/- 
mice, both the loss of Blimp-1 expression and the inability to downregulate BIM have been 
suggested to contribute to increased apoptosis of plasma cells and thus decreased antibody titres 
(Ou et al., 2012). 
In agreement with previous studies, we found that TACI was expressed on all mature B cell 
subsets but at higher levels on B-1 and MZB cells (Katsenelson et al., 2007). However, on 
bumble MZB and FOB cells, TACI was not detectable at steady state. Inducible TACI 
expression is achieved through BCR and TLR ligation, but we found that on bumble B cells 
TACI was upregulated poorly in response to anti-IgM and CpG and only partially in response 
to LPS (Fig. 12A). Furthermore, despite their partial upregulation of TACI, bumble B cells 
remained unresponsive towards TACI ligands (Fig. 14B). 
APRIL and BAFF, through TACI, mediate downregulation of the pro-apoptotic protein BIM 
to promote plasma cell survival. In TACI-/- mice, both the loss of Blimp-1 expression and the 
inability to downregulate BIM have been suggested to contribute to increased apoptosis of 
plasma cells and thus decreased antibody titres (Ou et al., 2012). BAFF and BCMA expression 
were normal in bumble, further suggesting that the defect can be attributed to TACI expression 
and function. Altogether, these observations hint at a role for IκBNS in TACI-mediated 
survival, PC generation, and antibody production in TI responses. 
 
 
Figure 14. TACI expression and function in bumble is attenuated. (A) TACI expression on wildtype and bumble 
B cells after 48 hours of anti-IgM and LPS stimulation. (B) High concentrations of LPS (10 µg/ mL) induced the 
generation of antibodies and CD138+ cells, whereas low concentrations of LPS (100 ng/ mL) were less efficient 
in both read-outs. TACI ligation is known to enhance antibody responses towards low concentrations of LPS. 
Wildtype B cells exhibited increased antibody production, PC generation, and survival when APRIL was added to 
cultures with low LPS concentrations. However, bumble B cells did not respond to APRIL co-stimulation as they 
were unable to produce antibodies and CD138+ cells and exhibited increased cell death compared to wildtype. 
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4.6 PC differentiation is dysregulated in IκBNS-deficient B cells 
To gain further insight into the absence of PCs in bumble, we evaluated expression of 
transcription factors that are necessary for the regulation of PC differentiation. Pax5, which 
controls the expression of the B cell specific gene programme, is downregulated in cells 
committing to PC fate to allow for efficient PC differentiation (Nera et al., 2006). On the other 
hand, IRF4 and Blimp-1 are upregulated and act in concert to establish expression of 
PC-specific genes (Ochiai et al., 2013; Minnich et al., 2016). 
Despite being able to upregulate IRF4, bumble B cells were unable to fully downregulate Pax5 
in IRF4+ cells. Since differentiation into PCs is a process that has been linked to cellular 
divisions, we investigated changes in Pax5, IRF4, and Blimp-1 expression per division cycle. 
Bumble B cells exhibited higher Pax5 expression consistently throughout all divisions and 
upregulated Blimp-1 more rapidly than wildtype B cells (Fig. 15B). Nevertheless, after the 
6th division cycle, cells committing to PC fate were drastically reduced. 
Blimp-1 has been shown to gradually increase during differentiation, with splenic ASCs being 
defined as both Blimp-1int and Blimp-1hi and bone marrow plasma cells as Blimp-1hi (Kallies 
et al., 2004). Considering that c-myc is a direct target of Blimp-1 repression (Lin et al., 1997), 
high Blimp-1 expression is thought to contribute to cell-cycle exit during plasma cell 
generation whereas intermediate Blimp-1 expression potentially permits proliferation of cells 
in transient stages of PC differentiation. Thus, the accelerated induction of Blimp-1 expression 
in bumble mice might compromise the proliferative capacity of differentiating cells. In 
addition, premature expression of Blimp-1 has been associated with increased apoptosis (Setz 
et al., 2018). Investigations in the expression of proteins associated with apoptosis and survival, 
such as and Bcl-2, might offer clues as to whether rapid increase of Blimp-1 expression in the 
absence of IκBNS results in enhanced cell death and thereby limits terminal differentiation. 
 
 
Figure 15. Reduced PC generation and alterations in regulation of PC differentiation in bumble. (A) LPS was 
injected intravenously in mice and the presence of PBs and PCs was evaluated after 3 days. LPS induced 
B220+CD138+ PBs and B220-CD138+ PCs in wildtype but not in bumble mice. (B) B cells were labelled with CTV, 
cultured for 3.5 days with LPS, and then stained for the expression of Pax5, IRF4, and Blimp-1. Expression is 
shown for the Pax5lo, IRF4+, and Blimp-1+ subpopulations per division cycle. 
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4.7 Validation and phenotypic characterisation of nfkbidB- mice 
The failure to mount humoral responses in bumble mice also affected TD antigen responses 
(Arnold et al., 2012). To distinguish between defects in the B cell compartment from those in 
the T cell compartment, we generated the B cell conditional Cd79aCre/+nfkbidfl/fl strain in paper 
III to address the role of IκBNS in TD responses. Cre-mediated excision of the LoxP flanked 
nfkbid alleles was validated by nfkbid mRNA measurements, as we did not detect nfkbid 
mRNA in B cells isolated from nfkbidB- mice. To our surprise, as we presumed that the non-
functional nfkbid mRNA transcripts in bumble were degraded, we detected nfkbid transcripts 
in bumble at much higher levels compared to wildtype. 
As shown in paper I, the loss of B-1a cells in the absence of IκBNS is an intrinsic effect. The 
frequencies of the B-1a cell population in nfkbidB- mice could thus be considered an indirect 
validation of nfkbid deletion efficiency. Although severely reduced, a small proportion of B-1a 
cells were detectable in the nfkbidB- mice, suggesting that not in all B cells excision was 
successful. Frequencies of B-1a cells correlated with serum IgM titres, which were also 
severely reduced in nfkbidB- mice. We found normal frequencies of the transitional B cell 
subsets and MZB cells in nfkbidB- mice, unlike in bumble, where these compartments are 
affected (Ádori et al., 2018). 
 
4.8 TD responses in nfkbidB- mice reveal normal GC formation but 
attenuated production of antigen-specific antibodies of the 
IgG2c and IgG3 isotype 
 
We examined GC formation and antibody responses to the TD antigens rSFV-βGal and NP-
CGG. Both βGal-specific and NP-specific IgG3 titres were reduced, and in line with reduced 
natural serum IgG3 levels, suggests a general class switching defect to the IgG3 isotype (Fig. 
16A). Switching to IgG3 is rapidly triggered during infections and is promoted by IL-4, IL-10, 
and IL-21 (Brière et al., 1994; Fujieda et al., 1995; Malisan et al., 1996; Pène et al., 2004). As 
IL-10 production in IκBNS-deficient mice is compromised (Miura et al., 2016), this could 
explain their inability to produce antibodies of the IgG3 isotype. However, it has been shown 
that in LPS cultures supplemented with IL-4, switched transcripts of IgG3 were undetectable 
in IκBNS KO B cells, suggesting that even in the presence of IgG3-inducing cytokines, 
switching is defective (Touma et al., 2011). 
Furthermore, serum titres of IgG2c in naïve as well as in rSFV-βGal immunized nfkbidB- mice 
were also reduced (Fig. 16A). Antibodies of the IgG2a/ IgG2c are preferentially induced by 
viral infection but were not elicited in IκBNS KO mice exposed to the murine-adapted 
influenza virus PR8 either (Coutelier et al., 1988; Touma et al., 2011). It has been shown that 
virus-like particles directly act on B cells to produce IgG2b and IgG2c antibodies through 
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TLR7/9-induced MyD88 signaling (Hou et al., 2011). Intact MyD88 signaling in B cells is 
necessary for their ability to prime T cells to differentiate and produce IFN-γ, which in turn 
acts on B cells to promote IgG2a/ IgG2c class switching via T-box transcription factor (T-bet) 
expression (Finkelman et al., 1988; Peng et al., 2002; Barr et al., 2009). It is possible that NF-
κB activation upon MyD88 signaling is altered in the absence of IκBNS and interferes with the 
ability of B cells to support T cell differentiation and/ or function. Another possibility is that 
attenuated signaling downstream of IFN-γR, TLR7/9 or other PRRs restricts T-bet expression 
in IκBNS-deficient B cells. Measurements of IFN-γ in serum, IFN-γ+ T cells, and T-bet 
expression in B cells from rSFV-βGal immunized mice could offer more insight into these 
mechanisms. 
As for NP-specific and βGal-specific IgG1, titres were comparable between nfkbidB- and 
nfkbidB+ mice, suggesting that IκBNS is not required for switching to IgG1. We noticed a 
tendency towards lower GC B cell frequencies in response to rSFV-βGal, but similar 
frequencies in response to NP-CGG (Fig. 16B). TACI-/- mice have been shown to produce 
larger numbers of GC B cells and TFH cells in response to NP-CGG. TACI is able to sequester 
BAFF and prevent its binding to BAFFR, which would induce ICOSL surface expression on 
B cells (Ou et al., 2012). We have shown in paper II that TACI upregulation is more severely 
impaired upon BCR than TLR engagement. Possibly, NP-CGG and rSFVβGal could 
differentially induce TACI upregulation and/or signal through PRRs, explaining the observed 
differences in GC B cell expansion. Thus, as there were no further indications that GC 
formation or plasma cell differentiation was defective, the results from antigen-specific 
antibody titres only revealed a defect in class switching. Thus, the finding that nfkbidB- mice 
were able to form GCs and produce Ag-specific IgG1, suggests that the impaired TD responses 
observed in bumble were primarily due to defects in the T cell compartment. 
 
 
 
Figure 16. GC B cell frequencies. Mice were immunised with rSFV-βGal i.p. or NP-CGG in Addavax s.c. 
(A) β-Gal-specific IgG1, IgG2c, and IgG3 titres. (B) Representative flow cytometry plots showing 
B220+GL7+CD95+ GC B cells at indicated time points. 
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4.9 Human plasma cell differentiation in vitro 
Certain phenotypic characteristics of the bumble mice, most notably low serum IgM titres and 
poor antibody responses towards polysaccharide antigens, are similar to symptoms of patients 
suffering from immunodeficiencies. Nowadays, the application of next generation sequencing 
methods has allows for identification of an increasing number of mutations associated with 
CVID, including mutations in the NF-κB pathway (Chen et al., 2013; Fliegauf et al., 2015; 
Boztug et al., 2016; Kuehn et al., 2017; Klemann et al., 2019). As highlighted by our findings 
in paper II, defects in the NF-κB pathway can result in altered transcriptional regulation of PC 
differentiation which contributes to impaired humoral responses. Thus, our aim for paper IV 
was to translate our PC differentiation assays to the human context. 
To develop a robust protocol, we compared several stimulation conditions and optimised a flow 
cytometry panel for the detection of in vitro generated plasma cells. Two populations with PC 
characteristics were detectable, namely CD38+IRF4hiPax5lo cells and CD38+IRF4intPax5lo cells. 
The latter population contained both Blimp-1+ and Blimp-1- cells at day 3.5, and on day 6 all 
cells were Blimp-1- (Fig. 17). This suggests that they developed from the CD38+IRF4hiPax5lo 
population and gradually lost Blimp-1 expression as well as stopped cycling. Both the 
CD38+IRF4hiPax5lo and CD38+IRF4intPax5lo population contained cells that expressed IgG 
intracellularly. 
To ensure that our protocol was applicable to patient samples, which are commonly stored at 
-80° C or in liquid nitrogen, we evaluated differentiation of cells from cryopreserved samples 
compared to fresh samples. Additionally, a genuine concern for working with CVID patient 
samples is that often circulating memory B cells are reduced, and as memory B cells have a 
faster differentiation kinetic than naïve B cells, samples with low memory B cell numbers could 
skew the outcome of the assay. Memory B cells did indeed differentiate more rapidly than 
naïve B cells, but both cell subsets generated CD38+IRF4hiPax5lo cells and secreted IgG. 
 
 
 
 
Figure 17. Human PC 
differentiation in vitro. 
(A) Isolated B cells from healthy 
donor blood were stimulated in 
vitro to promote PC differentiation. 
(B) Expression of IRF4 and Pax 
revealed three distinct cell 
populations. Population P2 and P3 
contained cells undergoing PC 
differentiation, as evidenced by 
their upregulation of surface CD38 
expression and intracellular IgG 
levels. 
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4.10 Evaluation of metabolic state in differentiated human B cells 
Differentiation of activated cells is characterized by a profound switch in intracellular 
metabolic activity. Activated B cells, via the PI3K signaling pathway, increase their glycolysis 
and oxidative phosphorylation to support ER expansion and proliferation (Doughty et al., 2006; 
Caro-Maldonado et al., 2014). Cellular division of lymphocytes generates an uneven 
distribution of PI3K signaling strength in progenitor cells with diverging fates; cells exhibiting 
low PI3K activity continue to self-renew whereas cells exhibiting high PI3K activity favour 
differentiation (Lin et al., 2015; Adams et al., 2016). Subsequent commitment to the plasma 
cell fate has been shown to coincide with reduced levels of mitochondrial reactive oxygen 
species (mROS), as well as decreased mitochondrial mass and potential (Jang et al., 2015). 
Mutations in both catalytic and regulatory PI3K subunits have been identified in patients with 
primary immunodeficiency and are associated with impaired polysaccharide responses, 
respiratory tract infections, and decreased frequencies of switched memory B cells (Lucas et 
al., 2014a; Lucas et al., 2014b; Deau et al., 2015; Elgizouli et al., 2016; Avery et al., 2018). 
The strong link between factors involved in regulation of metabolic activity and differentiation 
fate prompted us to evaluate the mitochondrial metabolic state and mitochondrial ROS (mROS) 
production. Human cells were subjected to fixation before flow cytometry acquisition and the 
mitochondrial dyes that were compatible with paraformaldehyde fixation were limited. We 
used MitoTracker Deep Red (MTDR) to measure mitochondrial mass and potential, and 
MitoSOX to measure mROS production. At day 3.5, B cells that had proliferated and 
upregulated CD38 had increased mitochondrial mass and potential. We observed a similar 
trend at day 6 albeit at lower expression compared to day 3.5. We found increased mROS levels 
in proliferated CD38- cells, whereas CD38+ cell exhibited reduced mROS (Fig. 18). 
Figure 18. Changes in metabolic state in differentiating human B cells (unpublished data). Cells were labelled 
with CTV, cultured with stimulation III and stained with the MTDR and MitoSOX dyes in addition to anti-CD38. 
(A) Flow cytometry plots showing gating strategy to identify unproliferated activated B cells (act B), proliferated 
CD38- cells and proliferated CD38+ B cells. (B) Expression levels of MTDR and MitoSOX. 
 
The read-outs that were based on MTDR and MitoSOX resulted in considerable variation 
between donors but also between experiments. As a result, we omitted this assay from paper 
IV to ascertain that all included assays were reliable and applicable to patient samples. 
Nevertheless, further optimization of assays to evaluate metabolic alterations during plasma 
cell differentiation in human B cells are of interest for future investigations. 
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5 CONCLUDING AND PROSPECTIVE REMARKS 
 
The work described in this thesis contributes to our understanding of the function of IκBNS in 
humoral responses and addresses relevant implications for human immune disorders. 
In this chapter, the key findings are briefly summarised. 
First, we addressed the absence of B-1a cells in bumble mice and aimed to identify at which 
stage during B-1 a cell development IκBNS expression is essential. In paper I, we have 
demonstrated that the development of B-1a cells occurs via a B220loCD5+ transitional B cell 
stage which was lacking in mice deficient in IκBNS. Considering that the IgM+CD93+ splenic 
TrB cell population was intact, IκBNS is most likely required for the transition from TrB cell 
to TrB-1a cell. Using chimeric cell transfer experiments, we showed that the inability of 
IκBNS-deficient bone marrow and foetal liver cells to generate B-1a cells is cell-intrinsic. In 
addition, the absence of B-1a cells in bumble partially explains why they are unable to respond 
to TI antigens, as the transfer of wildtype peritoneal cells restored the NP-Ficoll response. Even 
though the identification of a B-1a lineage committed transitional B cell population in this 
paper contributes to our understanding of B-1a cell development, how the development of B-
1b cells is differentially regulated is as of yet still poorly understood. Furthermore, it is widely 
accepted that B-1a cells preferentially express VH12/Vκ4 and VH11/Vκ14 BCRs, are selected 
on self-antigen, and exhibit stronger tonic BCR signaling relative to B-2 cells. Nevertheless, to 
which extent the BCR contributes to the B-1 and B-2 lineage commitment continues to be a 
controversial topic. 
Next, we investigated potential reasons for the impaired humoral responses to TI antigens in 
bumble mice. The surface receptor TACI is known to be important for optimal TI responses 
and TACI expression and function was shown to be compromised in mice with defective BCR 
signaling. This led us to examine TACI expression and function in bumble. In paper II, we 
show that TACI was not expressed on bumble FOB and MZB cells at steady state and 
upregulation upon stimulation was attenuated. Furthermore, antibody responses to low 
concentrations of LPS combined with TACI ligands APRIL or BAFF were enhanced in 
wildtype cells but not in bumble cells. As there have not been many studies aimed at identifying 
binding partners or target genes of IκBNS, it is unknown whether IκBNS is directly or 
indirectly involved in the expression of TACI. Additionally, since ligand binding to TACI 
induces activation of the classical NF-κB pathway, it is possible that IκBNS is needed 
downstream of TACI signaling. 
We then proceeded to evaluate PC differentiation in response to LPS. Frequencies of PBs and 
PCs in bumble were severely reduced compared to wildtype in vivo. Similarly, B cells derived 
from bumble proliferated less and generated less CD138+ cells compared to wildtype B cells in 
vitro. We therefore assessed expression of transcription factors that are central to regulation of 
the PC differentiation, namely Pax5, IRF4, and Blimp-1. We showed that LPS-stimulated cells 
that expressed high levels of IRF4 were unable to fully downregulate Pax5. In addition, 
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evaluation of Pax5, IRF4, and Blimp-1 expression levels in relation to cellular division revealed 
a pattern of rapid differentiation in the early division stages but a failure to commit to terminal 
differentiation in the late division stage. As Blimp-1 is imperative for terminal differentiation 
of cells committing to PC fate, and Blimp-1 is present in bumble cells yet terminal PC 
differentiation is dysregulated, ongoing studies in the group are focussing on the function of 
Blimp-1 in bumble cells. 
The generation of nfkbidB- mice, in which IκBNS is selectively deleted in B cells, allowed us 
to interrogate the role of IκBNS in TD responses. In paper III, we show that nfkbidB- mice 
have severely reduced frequencies of B-1a cells, decreased natural IgM serum levels, and fail 
to respond to NP-Ficoll immunization. These results are in line with the intrinsic requirement 
of IκBNS for B-1a cell development shown in paper I. Upon immunization with the TD 
antigen rSFV-βGal, we observed normal βGal-specific IgG1 titres, but reduced βGal-specific 
IgG2c and IgG3 titres in nfkbidB- mice compared to nfkbidB+ litter mate control mice. 
Additionally, nfkbidB- mice exhibited lower frequencies of GC B cells, although the distribution 
of light zone and dark zone GC B cells was normal. The differential requirement for IκBNS in 
class-switching to distinct isotypes remains a topic for future exploration. The modest 
alterations observed in GC responses combined with the reduction in antigen-specific antibody 
titres in nkfbidB- mice suggests that the role of IκBNS in B cells during TD responses is limited 
to class switching, and that the absence of GC formation and antibody production in bumble 
mice to TD antigens are due to extrinsic requirements. 
Our finding that PC differentiation was dysregulated in bumble mice together with the strong 
association between mutations in NF-κB components and CVID, prompted us to design and 
validate robust methods suitable for evaluation of PC differentiation defects in 
immunodeficient patients. In paper IV, we compared four different stimulation conditions for 
their potential to induce PC differentiation from primary human B cells in vitro. We 
demonstrated that in vitro induced PC differentiation generated a CD38+IRF4+Blimp-1+ 
population expressing intracellular IgG. We have showed that the protocol is applicable to B 
cells from cryopreserved PBMCs and naïve B cells, indicating that it is suitable also for patient 
material with low memory B cell counts. Currently, how certain mutations contribute to the 
development of CVID is not well understood. The methods developed in paper IV could help 
identify defects in PC differentiation in B cells from immunocompromised patients and provide 
more insight into how different mutations result in distinct clinical phenotypes. 
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7 POPULAR SCIENCE SUMMARY 
 
7.1 English 
From the moment we are born and each day for the rest of our lives, we are surrounded by 
microbes in our environment. The majority of microbes are harmless, but current estimates 
suggest that there are around 1400 microbes that cause human diseases (Microbiology by 
numbers, 2011). Harmful microbes are referred to as pathogens, and include viruses, bacteria, 
fungi, protozoa and helminths. It is thought that half of all humans that have lived have died 
from infectious diseases, and even now, 17 million people a year are lost to infectious diseases. 
New pathogens emerge repeatedly and drug resistance in pathogens is unfortunately becoming 
an increasing problem. It is not only pathogens that are a threat to our health though, cancer, 
heart conditions and metabolic diseases arise from within the body, sometime influenced by 
our lifestyle.  
So how do we stay healthy and recover from infections? The body has defence mechanisms 
that recognise and eliminate threats, both internal and external. The immune system is 
composed of several cell types and tissues, each with their own unique function and 
characteristics, that collaborate to achieve their common goal of keeping us safe. The early 
stage of an infection is dealt with by the innate part of the immune system, which distinguishes 
self from non-self through the recognition of molecules that are foreign to healthy cells and 
tissues. Proteins, such as complement, anti-microbial peptides, and antibodies, bind and inhibit 
pathogens and abnormal cells. Binding also targets pathogens to cells that are specialised in 
absorbing and breaking down external particles and cells that induce cell death. When dealing 
with complex pathogens, cells of the innate immune system recruit and activate cells of the 
adaptive immune system. Key characteristics of the adaptive immune system are specificity 
and memory: the adaptive immune system targets elements that are unique to a particular 
pathogen and is capable of swiftly eliminating that same pathogen upon a second encounter. 
This specific and protective response is established by, on one hand, the elimination of infected 
and abnormal cells by T cells, and on the other hand, the production of antibodies by B cells. 
Due to their production of highly effective neutralising antibodies, B cells are key mediators of 
long-lasting protective immune responses induced by vaccines. 
Immune responses can be extremely potent and precisely therefore it is essential that they are 
well-balanced and tightly regulated. Cells need to communicate and instruct each other, 
respond to pathogens in an appropriate manner, and dissolve the immune reaction as soon as 
the threat is eliminated, in order to prevent excessive collateral damage to host cells and tissues. 
Defects in the immune system can leave us vulnerable to infections and prone to developing 
immune deficiencies, autoimmune diseases or even cancer. 
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The focus of my thesis work has been understanding immune responses mediated by antibody-
producing B cells. Different types of B cells exist based on how they develop, their function, 
and their localisation in the body. Those known as B-1 cells contribute to the innate immune 
system by producing antibodies at steady-state which easily recognize and respond to 
components of bacterial cell walls. Those known as B-2 cells contribute to the adaptive immune 
system by secreting antibodies that are more finetuned to specifically recognise particular 
pathogen components but also exert appropriate effector functions. In general, B-1 cells 
respond to antigens that can activate B cells without the help of T cells, which are referred to 
as T cell-independent (TI) antigens. B-2 cells respond to protein antigens, which generally 
require the help of T cells to induce effective antibody responses, and are therefore referred to 
as T cell-dependent (TD) antibody responses. 
The process of a B cell to develop into a plasma cell whose sole purpose is to secrete large 
quantities of antibodies with a single specificity is a very meticulous one. This process requires 
B cells to integrate cues from their environment and communicate with other immune cells 
through receptors on their surface that induce signaling via intracellular proteins. Often, these 
signals transmit into the nucleus where they change expression of genes. This leads to 
alterations in the cellular state from inactive to active, promoting cell migration, enabling 
interactions between immune cells, proliferation of cells to expand the magnitude of the 
ongoing response, and supports their effector functions. 
An important signaling pathway in B cells is the NF-κB pathway, named after the NF-κB 
proteins that are central to this pathway and alter gene expression upon their activation. The 
protein IκBNS regulates the activity of NF-κB proteins in the nucleus and modulates their effect 
on B cell development and function. Over the course of six years, I have studied the role of 
IκBNS by using mice that are entirely deficient in IκBNS, the bumble mice, and mice that are 
only deficient in IκBNS in their B cells, the nfkbidB- mice. 
In paper I, we show that without IκBNS a specific subset of B-1 cells, the B-1a cells, do not 
develop. B cells develop from stem cells and pass through several precursor stages before they 
are fully matured and functional. We identified a precursor stage that mainly generated B-1a 
cells but which was missing in bumble mice. B-1 cells are the main responders to TI antigens 
and, consistent with this, we found that the bumble mice were unable to establish antibody 
responses against TI antigens. 
In paper II, we found that activation of B cells from bumble mice was relatively normal up to 
24 hours, but cellular division was noticeably affected. TACI is a receptor expressed on the 
surface of B cells and is essential for efficient TI antibody responses. We found that TACI was 
not expressed on the surface of bumble B cells and not upregulated efficiently upon activation. 
Bumble B cells were also not able to respond to the proteins that bind and activate TACI. B 
cells destined to become plasma cells need to modify their gene expression to support their 
future function as antibody secreting cells. The proteins involved in these modifications, IRF4 
and Blimp-1, were induced rapidly in bumble B cells. Regardless, bumble B cells did not 
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develop into plasma cells. This suggests that ‘over-activation’ in bumble B cells is detrimental 
to the process of becoming plasma cells. 
In paper III, we used the nfkbidB- mice to better understand to which extent IκBNS was 
necessary for B cell function during TD antibody responses. We immunized nfkbidB- mice with 
TD antigens and found that although these mice produced antibodies, they were not able to 
change their antibody isotype, which is the part that determines their effector function. T cells 
behaved normally in these mice, suggesting that the role of IκBNS during TD responses is 
limited to plasma cell differentiation and isotype switching in B cells. 
In paper IV, with the knowledge we gained from papers I-III , we developed a method for 
evaluating the process of B cell activation and development into plasma cells for human B 
cells. Testing plasma cell development from patients suffering from immune disorders would 
provide more insights into how the disease develops. This would be beneficial to the diagnostic 
process or even for the identification of suitable targets for therapeutic interventions. 
In summary, the work presented in this thesis contributes to our understanding of processes 
that are fundamental to effective antibody responses and of direct relevance to immune 
disorders. 
 
7.2 Svenska 
Under hela livet är man omgiven av mikrober från vår miljö. Samtidigt som mest av mikrober 
är ofarligt, nuvarande beräkningar föreslå att det finns cirka 1400 mikrober som kan förorsaka 
sjukdom i människor (Microbiology by numbers, 2011). Farliga mikrober, hänvisa som 
patogen, inkludera virus, bakterier, svampar, protozoer och helminter (parasitiska maskar). 
Halv av människor som levde är tänkt att ha dött från smittsam sjukdomar. Även nu finns det 
17 miljoner av människor som döda från smittsam sjukdom varje år. Läkemedel resistans blir 
varje år en större problem med uppkomsten av ny patogen. Och patogener inte är ensam att 
hota hälsa av människor. Även om de utveckla från insidan av vår kroppen, cancer, 
kardiovaskulär och metabolisk sjukdomar kan vara också påverkat från miljö. 
Så hur kan man slå tillbaka smittsam sjukdomar och blir frisk? Kroppen äga 
försvarsmekanismer som kan identifiera och ta bort internt och externt hot: immunsystemet. 
Det system involvera flera typ av celler och vävnader som ha unik funktion och kännetecken 
medan fungera tillsammans att hålla oss frisk. 
Medfödd del av immunitet ta hand om tidigt stegar av infektion och särskilja intern mot externt 
komponenter genom erkännande av molekyler som frisk celler och vävnader bruka inte ha. 
Komplementproteiner, antimikrobiellt peptider och antikroppar binda och inhibera patogen och 
sjuk celler. Bindning också hjälpa att driva patogen mot celler som specialisera att internalisera 
och förgöra externt partiklar som kan inducera celldöd.  
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När medfödd immunsystemet hantera komplex patogen, det aktivera och rekrytera celler från 
adaptivt immunsystemet. Viktigt kännetecken av adaptiv immunsystemet är sina specificitet 
och minne: det kan identifiera och sikta partiklar som är unik för en specifik patogen att utlösa 
en snabb immunrespons när samma patogen smitta kroppen igen. Specifik och skyddande 
immunrespons är baserat på 1) ta bort smittat och onormal celler med T celler, 2) antikroppar 
produktion med B celler. B celler är viktigast för långvarigt effekt immunrespons efter vacciner 
emedan de producera väldigt effektiv neutraliserande antikroppar. 
Immunrespons kan vara extremt effektiv så de måste vara väl balanserat och tätt kontrollerad. 
Celler behöver kommunicera och informera med varandra, avvanda lämplig immunrespons för 
specifik patogen. De måste också stoppa immunrespons när hot är bort att förhindra indirekta 
skador för celler och vävnader. Om det finns problem i immunsystemet, man kan ha höger risk 
för infektion och vara benägna at immunbrister, autoimmuna sjukdomar och även cancer. 
Min PhD fokuserade om förståelse av immunrespons som är medierat med antikropp-
producerande B celler. Olika typ av B celler skillna med hur de utveckla, funktion och 
lokalisering i kroppen. B-1 celler medverka medfödd immunsystemet emedan de ständigt 
producera antikroppar som kan identifiera och slåss mot partiklar från bakteriecellväggar. B-1 
celler svara mot antigen som aktivera B celler utan hjälpa av T celler (T cell oberoende antigen; 
TI). B-2 celler medverka adaptivt del av immunsystemet med finstämd antikroppar som kan 
identifiera specifikt patogenpartiklar och leda till lämplig svar. B celler svara mot antigen som 
behöver T celler hjälp att inducera effektivt antikropprespons (T cell beroende antigen; TD). 
Att utveckla till plasmacell som kan producera stora mängder av antikroppar med unik 
specificitet, B celler behöver följa process som skulle integrera signaler från miljön, 
kommunikation med andra immunceller. Kommunikationen fungera genom receptor som 
inducera signalvägar i immuncellen och kan leda att andra genexpression i cellkärnan. Det kan 
aktivera cellen, inducera cellmigrering, stödja immuncellinteraktioner, cellspridning som leda 
till ökade immunrespons och support till effektfunktioner. 
NF-κB signalvägar är viktigt i B celler med centralt NF-κB proteiner som spela en stor roll och 
förändra genexpression efter de är aktiverat. IκBNS proteiner styra NF-κB aktivitet i cellkärnan 
och modulera NF-κB effekt över B celler utveckling och funktion. Över min 6 års-projekt 
studerade jag IκBNS roll i immunrespons och komparerade en musmodell helt utan IκBNS 
(bumble mus) mot en andra musmodell som inte ha IκBNS bara i B celler (nfkbidB- mus). 
I artikel I, vi demonstrerade att en subset av B-1 celler, B-1a celler, kan inte utveckla utan 
IκBNS. B celler utveckla från stamceller i flera stegar innan att vara fullt mogna och 
funktionellt. Vi identifierade en föregångare steg som generera huvudsaklingen B-1a celler och 
som saknas i bumble möss. Eftersom B-1 celler är ansvarig för TI antigen immunrespons, vi 
konfirmerade att bumble möss kunde inte utveckla antikropprespons mot TI antigen. 
I artikel II, vi hittades att B celler från bumble möss kan vara aktiverat för 24 timmar men att 
celldelning är påverkat. Vi studerade en receptor, TACI, som är uttryckat på cellytor av B celler 
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och är grundläggande för effektivt TI antikropprespons. I bumble möss, TACI är inte uttryckat 
på cellytor av B celler och inte uppreglerad effektiv efter aktivering. Bumble möss kunde inte 
utveckla immunrespons som binda och aktivera TACI. Att bli plasmaceller, B celler måste 
förändra deras genexpression att stödja ny funktion som antikropp utsöndrande celler. Proteiner 
involverande i dessa ändringar, IRF4 and Blimp-1, var snabb inducerat i bumble B celler. 
Oavsett kunde inte bumble B celler utveckla till plasmaceller. Det föreslår att ”överaktivering” 
av bumble B celler ha en skadlig effekt över process av blivande plasmaceller. 
I artikel III, nfkbidB- var använda att förstå hur IκBNS deltar i TD antikropprespons medlat av 
B celler. Vi immuneserade nfkbidB- möss med TD antigen och hittades att möss kunde 
producera antikroppar men de kunde inte förändra antikropp isotyp, som är viktigt att 
bestämma effektfunktion. T celler bete sig normalt i nfkbidB- möss som föreslår att IκBNS roll 
i TD antigenrespons är limiterat till plasmaceller differentiering och isotyp ändring i B celler. 
I artikel IV, vi samlade kunskap från artiklar I till III och utveckla en metod att evaluera 
process av human B celler aktivering och utveckling till plasmaceller. Att testa plasmaceller 
utveckling från patienter med immunsjukdomar skulle hjälpa att förstå hur sjukdomen 
utveckla. Det skulle också hjälpa med diagnosprocess och eventuellt identifiera mål för 
terapeutiskt interventioner. 
För att sammanfatta, detta avhandling bidraga med vår uppfattning av fundamentalt processer 
för en effektivt antikropprespons och är relevant för immunsjukdomar.  
 
7.3 Nederlands 
Vanaf het moment dat we geboren worden, worden we elke dag van ons leven omgeven door 
micro-organismen in onze omgeving. De meerderheid van deze micro-organismen is 
ongevaarlijk, maar huidige schattingen suggereren dat er ongeveer 1400 micro-organismen 
ziektes kunnen veroorzaken bij mensen (Microbiology by numbers, 2011). Schadelijke micro-
organismen worden pathogenen genoemd, en deze bestaan uit virussen, bacteriën, schimmels, 
protozoa, en parasitaire wormen. Er wordt gedacht dat de helft van alle mensen die ooit hebben 
geleefd overleden zijn aan de gevolgen van infectieziektes, en dat ook nu 17 miljoen mensen 
per jaar overlijden aan infectieziektes. Nieuwe pathogenen komen vaak op en resistentie tegen 
geneesmiddelen is een zich ontwikkelend probleem. Het zijn echter niet alleen pathogenen die 
een gevaar vormen voor onze gezondheid, kanker, hartkwalen, en metabole ziekten kunnen 
ontstaan in het lichaam, soms als gevolg van onze levensstijl.  
Maar hoe blijven we dan gezond en herstellen we van infecties? Het lichaam heeft zowel 
interne als externe verdedigingsmechanismen die gevaren herkennen en onschadelijk maken. 
Het immuunsysteem bestaat uit verscheidene soorten cellen en weefsels, elk met eigen unieke 
functies en eigenschappen, die samenwerken om hun gezamenlijke doel om ons te beschermen 
te bereiken. In het eerste stadium van een infectie treedt het aspecifieke, ofwel aangeboren, 
immuunsysteem op. Deze onderscheidt eigen van vreemd door het herkennen van moleculen 
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die gezonde cellen en weefsels niet hebben. Eiwitten zoals het complement systeem, 
antimicrobiële eiwitten, en antilichamen kunnen pathogenen en abnormale cellen binden en 
tegenwerken. Binding van deze eiwitten zorgt er daarnaast ook voor dat pathogenen herkend 
worden door gespecialiseerde cellen die deeltjes kunnen opnemen en afbreken, en andere 
gespecialiseerde cellen die ongezonde cellen kunnen aansturen tot celdood. Wanneer het om 
complexe pathogenen gaat, werven en activeren cellen van het aspecifieke immuunsysteem 
cellen van het adaptieve, ofwel verworven, immuunsysteem. De belangrijkste eigenschappen 
van het adaptieve immuunsysteem zijn specificiteit en geheugen. Dat wil zeggen dat het 
adaptieve immuunsysteem zich richt op unieke elementen van een pathogeen en het daarmee 
gemakkelijk en snel het pathogeen onschadelijk kan maken kan opruimen wanneer deze zich 
een volgende keer voordoet. Deze specifieke en beschermende respons is opgebouwd uit aan 
de ene kant het uit de weg ruimen van geïnfecteerde en abnormale cellen door T cellen, en aan 
de andere kant het produceren van antilichamen door B cellen. Door hun productie van zeer 
effectieve en neutraliserende antilichamen vervullen B cellen ook een essentiële rol in 
langdurige beschermende reacties op vaccinaties. 
Immuunreacties kunnen zeer krachtig zijn en daarom is het van belang dat deze goed 
gebalanceerd zijn en goed gecontroleerd worden. Cellen moeten met elkaar communiceren en 
elkaar instrueren, reageren op pathogenen op de juiste manier, en de immuunrespons 
beëindigen zodra het gevaar geweken is om zo schade aan eigen cellen en weefsels te 
minimaliseren. Defecten in het immuunsysteem kunnen ons vatbaar maken voor infecties en 
het ontwikkelen van immuundeficiënties, auto-immuniteit, en zelfs kanker. 
De focus van mijn thesis ligt op het begrijpen van de immuunrespons door antilichaam-
producerende B cellen. Er bestaan verschillende typen B cellen gebaseerd op hun ontwikkeling, 
functie, en plaats in het lichaam. Een bepaald type cellen, bekend als B-1 cellen, dragen bij aan 
het aangeboren immuunsysteem met een constante productie van antilichamen die algemene 
componenten van de bacteriële celwand herkennen. B-2 cellen dragen daarentegen meer bij 
aan het adaptieve immuunsysteem met een productie van antilichamen die preciezer en 
specifieke pathogenen herkennen, en ook gepaste effect mechanismen teweegbrengen. Over 
het algemeen reageren B-1 cellen op antigenen die B cellen kunnen activeren zonder de hulp 
van T cellen, ook wel T cel-onafhankelijke antigenen genoemd. B-2 cellen reageren 
daarentegen op eiwit-antigenen welke gewoonlijk de hulp van T cellen nodig hebben of 
effectieve antilichamen te produceren, dit wordt daarom ook wel T cel-afhankelijke 
antilichaam respons genoemd. 
Het proces waarin een B cel zich ontwikkelt tot een plasma cel, welke als enig doel heeft om 
grote hoeveelheden antilichamen uit te scheiden met een enkele specificiteit, is een zeer 
nauwkeurig proces. Dit proces vereist de B cel om signalen uit de omgeving te integreren en te 
communiceren met andere immuuncellen via de receptoren op zijn oppervlakte en 
daaropvolgend eiwitten binnenin de cel. Meestal dragen deze signalen door tot in de celkern 
waar ze de expressie van genen veranderen. Dit leidt er vervolgens toe dat de cel wordt 
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geactiveerd, gaat migreren, interacties met andere cellen aangaat, zich vermenigvuldigt om de 
grootte van de reactie te vergroten, en effector functies ontwikkelt. 
Een belangrijke signaaltransductie in B cellen is de zogenaamde ‘NF-κB pathway’, vernoemd 
naar de centrale NF-κB eiwitten die de genexpressie kunnen aanpassen als ze geactiveerd 
worden. Het eiwit IκBNS reguleert de activiteit van de NF-κB eiwitten in de celkern en regelt 
het effect op de ontwikkeling en activiteit van B cellen. De afgelopen zes jaar heb ik de rol van 
IκBNS bestudeerd door muizen te gebruiken die helemaal geen IκBNS hebben, genaamd 
bumble muizen, en muizen die alleen IκBNS missen in hun B cellen, genaamd nfkbidB- muizen. 
In artikel I, laten we zien dat zonder IκBNS een bepaalde tak van B-1 cellen, de B-1a cellen, 
zich in zijn geheel niet ontwikkelen. B cellen ontwikkelen vanuit stamcellen en doorgaan 
verschillende voorloper stadia voordat ze gerijpt en functioneel zijn. We hebben een voorloper 
stadium geïdentificeerd welke vooral B-1a cellen produceert maar welke misten in de bumble 
muizen. B-1 cellen zijn de belangrijkste cellen voor een reactie op T cel-onafhankelijke 
antigenen en we vonden dan ook dat de bumble muizen in zijn geheel geen antilichamen 
konden produceren tegen deze soort antigenen. 
In artikel II, laten we zien dat activatie van B cellen in bumble muizen de eerste 24 uur normaal 
verloopt, maar dat de celdeling daarna is aangetast. TACI is een receptor op de oppervlakte 
van B cellen en is essentieel voor een T cel-onafhankelijke antilichaam respons. We hebben 
aangetoond dat TACI niet op de oppervlakte van bumble B cellen voor komt, ook niet na 
activatie van de B cel. Bumble B cellen waren ook niet in staat te reageren op eiwitten die 
normaalgesproken binden aan TACI. B cellen die zich ontwikkelen tot plasmacellen moeten 
hun genexpressie aanpassen om hun toekomstige functie als antilichaam producerende cel te 
ondersteunen. De eiwitten die hierin betrokken zijn, IRF4 en Blimp-1, werden snel geactiveerd 
in bumble B cellen. Toch lukte het bumble B cellen niet om zich te ontwikkelen tot 
plasmacellen. Dit suggereert dat ‘over-activatie’ in bumble B cellen nadelig is voor het proces 
om een plasmacel te worden. 
In artikel III, hebben we nfkbidB- muizen gebruikt om een beter inzicht te krijgen in hoeverre 
IκBNS nodig is voor B cellen om te functioneren in een T cel-afhankelijke respons. We hebben 
nfkbidB- muizen geïmmuniseerd met T cel-afhankelijke antigenen en zagen dat ondanks dat 
deze muizen antilichamen produceerden, ze niet in staat waren van type antilichaam te wisselen 
wat belangrijk is voor het effect van het antilichaam. T cellen gedroegen zich normaal in deze 
muizen wat suggereert dat de rol van IκBNS tijdens een T cel-afhankelijke respons zich beperkt 
tot plasmacel ontwikkeling en het type antilichaam wat geproduceerd wordt. 
 
In artikel IV, met de kennis van artikelen I-III, ontwikkelden we een methode om het proces 
van B cel activatie en ontwikkeling tot plasmacel te evalueren voor humane B cellen. Het testen 
van de ontwikkeling van plasmacellen van patiënten met immuunstoornissen kan meer inzicht 
geven in hoe deze stoornissen zich ontwikkelen. Dit zou voordelig zijn voor het diagnostiek-
proces of zou zelfs voor identificatie van potentiële doelwitten voor therapeutische ingrijpen 
kunnen zorgen. 
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In het kort, het werk in deze thesis draagt bij aan onze kennis over de fundamentele processen 
van effectieve antilichaam respons en is van direct belang voor immuunstoornissen. 
 
7.4 Deutsch 
Schon von Geburt an sind wir unser ganzes Leben von Mikroben in unserer Umwelt umgeben. 
Die Mehrheit dieser Mikroben ist harmlos, aber aktuelle Schätzungen gehen davon aus, dass 
es rund 1400 Mikroben gibt, die Krankheiten beim Menschen verursachen können. Schädliche 
Mikroben werden als Pathogene bezeichnet und umfassen Viren, Bakterien, Pilze, Protozoen 
und Helminthen. Es wird angenommen, dass die Hälfte aller Menschen, die bisher gelebt haben 
an Infektionskrankheiten gestorben sind und selbst heute sterben noch 17 Millionen Menschen 
pro Jahr durch Infektionskrankheiten. Immer wieder treten neue Krankheitserreger auf und 
Arzneimittelresistenzen werden leider zu einem zunehmenden Problem. Es sind jedoch nicht 
nur die Pathogene, die unsere Gesundheit gefährden, sondern auch andere Krankheiten wie 
Krebs, Herz- und Stoffwechselerkrankungen, die manchmal auch von unserem Lebensstil 
beeinflusst werden können. 
Wie also bleiben wir gesund, bekämpfen Infektionen und erholen uns wieder von ihnen? Der 
Körper verfügt über Abwehrmechanismen, die sowohl interne als auch externe Bedrohungen 
erkennen und beseitigen. Das Immunsystem besteht aus verschiedenen Zelltypen und 
Geweben, von denen jedes spezifische Merkmale und Funktionen hat und die 
zusammenarbeiten, um das gemeinsame Ziel zu erreichen uns zu schützen. Der Anfang einer 
Infektion wird durch den angeborenen Teil des Immunsystems bekämpft, welcher „Selbst“ von 
„Nicht-Selbst“ unterscheidet, indem er Moleküle erkennt, die auf gesunden, körpereigenen 
Zellen nicht vorhanden sind. Proteine, wie das Komplement-System, antimikrobielle Peptide 
und Antikörper, binden Krankheitserreger sowie abnormale Zellen und hemmen diese somit. 
Durch das Binden von Pathogenen an verschiedene Proteine können die Krankheitserreger für 
andere Zellen sichtbar gemacht werden, die darauf spezialisiert sind, externe Partikel und 
Zellen aufzunehmen und abzubauen oder den Zelltod von infizierten Zellen zu induzieren. 
Wenn das angeborene Immunsystem jedoch auf komplexere Pathogene trifft, rekrutiert und 
aktiviert es Zellen des adaptiven Immunsystems. Schlüsselmerkmale des adaptiven 
Immunsystems sind seine Spezifität und sein Gedächtnis. Das adaptive Immunsystem zielt 
spezifisch auf Elemente ab, die für einen bestimmten Erreger einzigartig sind und kann diesen 
Erreger somit bei einer zweiten Begegnung schneller eliminieren. Diese spezifische, 
schützende Immunantwort ist abhängig von der Bekämpfung infizierter und abnormaler Zellen 
durch T-Lymphozyten (T-Zellen) und der Produktion von Antikörpern durch B-Lymphozyten 
(B-Zellen). Diese hochwirksamen, neutralisierenden Antikörper machen B-Zellen zu den 
Schlüsselmediatoren für lang anhaltende, schützende Immunantworten, die durch Impfstoffe 
induziert werden. 
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Da Immunantworten sehr stark sein können, ist es wichtig, dass sie ausgewogen und streng 
reguliert sind. Zellen müssen miteinander kommunizieren und sich gegenseitig anweisen, was 
zu tun ist, um die Krankheitserreger angemessen zu beseitigen und die Immunreaktion wieder 
zu beenden, sobald die Bedrohung beseitigt wurde. Nur so können übermäßige 
Kollateralschäden an körpereigenen Zellen und Geweben verhindert werden. Fehlerhaftes 
Verhalten vom Immunsystem kann uns anfälliger machen für Infektionen und sogar zu 
Immunschwächen, Autoimmunerkrankungen oder Krebs führen. 
Der Schwerpunkt meiner Doktorarbeit lag darin, Immunantworten zu verstehen, die durch die 
Antikörper-produzierenden B-Lymphozyten vermittelt werden. Es gibt verschiedene Arten 
von B-Zellen, abhängig von Entwicklung, Funktion und Lokalisierung im Körper. B-1-Zellen 
tragen zum angeborenen Immunsystem bei, indem sie im normalen Zustand Antikörper 
produzieren, die Komponenten von Bakterien leicht erkennen und darauf reagieren. B-2-Zellen 
hingegen tragen zum adaptiven Immunsystem bei, indem sie Antikörper sekretieren, die 
bestimmte Pathogenkomponenten extrem spezifisch erkennen und geeignete 
Effektorfunktionen ausüben. Im Allgemeinen reagieren B-1-Zellen auf Antigene, die B-Zellen 
ohne die Hilfe von T-Zellen aktivieren können und als T-Zell-unabhängige (TI) Antigene 
bezeichnet werden. B-2-Zellen reagieren auf Proteinantigene, die im Allgemeinen die Hilfe 
von T-Zellen benötigen, um wirksame Antikörperantworten zu induzieren und werden daher 
als T-Zell-abhängige (TD) Antikörperantworten bezeichnet. 
Die Entwicklung einer B-Zelle bis hin zu einer Antikörper-produzierenden Plasmazelle ist sehr 
genau geregelt. Die Aufgabe der Plasmazellen besteht darin große Mengen von Antikörpern 
mit einer einzigen Spezifität zu produzieren. Dieser Weg erfordert, dass B-Zellen Merkmale 
aus ihrer Umgebung wahrnehmen und mit anderen Immunzellen kommunizieren. Dies 
geschieht über Rezeptoren auf ihrer Zell-Oberfläche, welche die Signalübertragung über 
intrazelluläre Proteine induzieren. Oft übertragen sich diese Signale in den Zellkern, wo sie die 
Genexpression verändern. Abhängig von den verschiedenen Signalen können verschiedene 
Parameter in der Zelle beeinflusst werden: der zelluläre Zustand von inaktiv zu aktiv, 
Förderung der Zellmigration, erhöhte Interaktionen zwischen Immunzellen, erhöhte 
Zellteilung und Unterstützung der Effektorfunktionen. 
Ein wichtiger Signalweg in B-Zellen ist der NF-κB-Weg, benannt nach den NF-κB-Proteinen, 
die für diesen Weg von zentraler Bedeutung sind und die Genexpression bei ihrer Aktivierung 
verändern. Das Protein IκBNS reguliert die Aktivität von NF-κB-Proteinen im Zellkern und 
moduliert deren Wirkung auf die Entwicklung und Funktion von B-Zellen. Über sechs Jahre 
lang habe ich die Rolle von IκBNS untersucht, indem ich Mäuse verwendet habe, denen IκBNS 
entweder vollständig fehlt (bumble-Mäuse) und Mäuse, denen IκBNS nur in den B-Zellen fehlt 
(nfkbidB -Mäuse). 
In Artikel I zeigen wir, dass sich ohne IκBNS eine bestimmte Untergruppe von B-1-Zellen, 
die B-1a-Zellen, nicht entwickelt. B-Zellen entwickeln sich aus Stammzellen und durchlaufen 
mehrere Vorstufen, bevor sie vollständig ausgereift und funktionsfähig sind. Wir identifizierten 
ein Vorläuferstadium, das hauptsächlich B-1a-Zellen erzeugte, aber in bumble-Mäusen fehlte. 
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B-1-Zellen sind normalerweise die Hauptantwortenden auf T-Zell-unabhängige Antigene und 
in Übereinstimmung damit fanden wir, dass die bumble-Mäuse keine Antikörperantworten 
gegen T-Zell-unabhängige Antigene etablieren konnten. 
In Artikel II fanden wir, dass die Aktivierung von B-Zellen aus bumble-Mäusen bis zu 24 
Stunden relativ normal war, die Zellteilung jedoch merklich beeinflusst wurde. TACI ist ein 
Rezeptor, der auf der Oberfläche von B-Zellen exprimiert wird und für effiziente T-Zell-
unabhängige- Antikörperantworten essentiel ist. Wir haben herausgefunden, dass TACI nicht 
auf der Oberfläche von bumble-B-Zellen exprimiert war und bei Aktivierung auch nicht 
effizient hochreguliert wurde. Bumble-B-Zellen waren auch nicht in der Lage, auf die Proteine 
zu reagieren, die TACI binden und aktivieren. B-Zellen, die dazu bestimmt sind, Plasmazellen 
zu werden, müssen ihre Genexpression verändern, um ihre zukünftige Funktion als Antikörper-
sekretierende Zellen zu unterstützen. Die Proteine, die an diesen Veränderungen beteiligt sind, 
IRF4 und Blimp-1, wurden schnell in bumble-B-Zellen hochreguliert. Unabhängig davon 
entwickelten sich die bumble-B-Zellen trotzdem nicht zu Antikörper-sekretierenden 
Plasmazellen. Dies deutet darauf hin, dass eine „Überaktivierung“ in bumble-B-Zellen deren 
Entwicklung zu Plasmazellen negativ beeinträchtigt. 
In Artikel III verwendeten wir die nfkbidB--Mäuse, um besser zu verstehen, inwieweit IκBNS 
für die B-Zell-Funktion während der T-Zell-abhängigen Antikörperantworten notwendig war. 
Wir immunisierten nfkbidB--Mäuse mit T-Zell-abhängigen Antigenen und stellten fest, dass 
diese Mäuse zwar Antikörper produzierten, jedoch ihren Antikörper-Isotyp nicht ändern 
konnten, welcher ihre Effektorfunktion bestimmt. Die T-Zellen verhielten sich bei diesen 
Mäusen normal, was darauf hindeutet, dass die Rolle von IκBNS während der T-Zell-
abhängigen Immunantworten auf die Differenzierung von Plasmazellen und den Isotypwechsel 
in B-Zellen beschränkt ist. 
In Artikel IV haben wir mit den Erkenntnissen aus Artikeln I-III eine Methode entwickelt, mit 
der wir die Aktivierung von B-Zellen und deren Entwicklung zu Plasmazellen in menschlichen 
B–Zellen untersuchen können. Das Testen der Plasmazellen-Entwicklung in Patienten mit 
verschiedenen Immunerkrankungen würde mehr Einblicke in die Entwicklung der Krankheit 
liefern. Dies wäre hilfreich für die Diagnose oder sogar für die Identifizierung möglicher Ziele 
für therapeutische Ansätze. 
Zusammengefasst tragen die in dieser Doktorarbeit vorgestellten Ergebnisse zum Verständnis 
von Prozessen bei, die für wirksame Antikörper-Reaktionen von grundlegender Bedeutung 
sind und eine direkte Relevanz für Immunerkrankungen haben. 
 
7.5 Español 
Desde que nacemos y cada día durante el resto de nuestras vidas, nos encontramos rodeados 
de microbios en el ambiente. Aunque la mayoría de microbios no son perjudiciales, algunas 
estimaciones apuntan a que hay alrededor de 1400 microbios que causan enfermedades a los 
 64 
humanos (Microbiology by numbers, 2011). Los microbios que son perjudiciales son llamados 
agentes patógenos, y éstos incluyen virus, bacterias, hongos, protozoos y helmintos. Se cree 
que la mitad de todos los seres humanos que han existido han muerto a causa de enfermedades 
infecciosas, e incluso ahora, 17 millones de persones mueren cada año a causa de éstas. Nuevos 
patógenos están surgiendo constantemente y la resistencia a fármacos que desarrollan se está 
convirtiendo desafortunadamente en un problema cada vez mayor. No solamente los agentes 
patógenos suponen un riesgo para nuestra salud, sino que otras enfermedades como el cáncer, 
enfermedades cardíacas y trastornos metabólicos son originados en nuestro propio cuerpo, en 
ocasiones influenciadas por nuestro estilo de vida.  
Luego, ¿cómo podemos mantenernos saludables y recuperarnos de infecciones? El cuerpo 
cuenta con un mecanismo de defensa capaz de reconocer y eliminar agresiones tanto internas 
como externas. El sistema inmune está compuesto por diversos tipos celulares y tejidos, cada 
uno de ellos con funciones y características propias, que colaboran para alcanzar su meta 
común que es mantenernos a salvo. De la etapa más temprana de la infección se encarga el 
sistema inmune innato, el cual distingue entre lo propio y lo ajeno a través del reconocimiento 
de moléculas que no suelen encontrarse en células y tejidos sanos. Proteínas, como por ejemplo 
el complemento, péptidos antimicrobianos y los anticuerpos se unen e inhiben patógenos y 
células que sean anormales. Esta unión también sirve para marcar los agentes patógenos para 
células que están especializadas en absorber y degradar moléculas externas y células que 
inducen muerte celular. A la hora de lidiar con agentes patógenos complejos, las células del 
sistema inmune innato reclutan y activan células del sistema inmune adaptativo, el cual destaca 
por su especificidad y memoria: el sistema inmune adaptativo reconoce elementos que son 
únicos para cada agente patógeno en particular y tiene la capacidad de eliminarlo rápidamente 
al encontrase de nuevo con él. Esta respuesta específica y protectora se debe por un lado a la 
eliminación de las células infectadas y anormales por parte de las células T y, por otro lado, a 
la producción de anticuerpos por parte de las células B. Gracias a su producción de anticuerpos 
neutralizantes altamente efectivos, las células B son mediadores clave en las respuestas 
inmunes protectoras a largo plazo que inducen las vacunas.  
Las respuestas inmunes pueden llegar a ser extremadamente potentes y es por este motivo que 
es necesario que estén correctamente equilibradas y altamente reguladas. Las células deben ser 
capaces de mantener una comunicación e informarse entre ellas, de responder a los agentes 
patógenos de forma adecuada y de finalizar la respuesta inmune tan pronto como haya sido 
eliminado el peligro para evitar un exceso de daños colaterales a las células y tejidos del 
huésped. Defectos en el sistema inmune nos hacen vulnerables frente a infecciones y 
susceptibles a desarrollar inmunodeficiencias, enfermedades autoinmunes o incluso cáncer.  
Mi tesis se ha centrado en entender las respuestas inmunes mediadas por células B productoras 
de anticuerpos. Existen distintos tipos de células B en base a cómo éstas se desarrollan, su 
función y la posición que ocupan en el cuerpo. Las llamadas células B-1 contribuyen al sistema 
inmune innato al producir anticuerpos en condiciones normales que fácilmente reconocen y 
responden a componentes de las paredes celulares bacterianas. Las células B-2 contribuyen al 
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sistema inmune adaptativo al secretar anticuerpos especializados en reconocer componentes 
específicos de los agentes patógenos y también en ejercer determinadas funciones efectoras. 
En general, las células B-1 responden a antígenos que activan células B sin la ayuda de las 
células T, los cuales son denominados antígenos independientes de célula T (T cell-
independent, TI). Las células B responden a antígenos proteicos que generalmente requieren 
de la ayuda de las células T para inducir respuestas de anticuerpos efectivas, y son por lo tanto 
denominadas respuestas de anticuerpos dependientes de célula T (T cell-dependent, TD).  
 
El proceso por el cual una célula B se convierte en célula plasmática cuyo único cometido es 
el de secretar grandes cantidades de anticuerpos con una única especificidad es altamente 
preciso. Este proceso requiere que la célula B integre las señales que le llegan de su ambiente 
y que se comunique con otras células inmunitarias a través de receptores que tiene en su 
superficie que inducen una señalización a través de proteínas intracelulares. Todo esto supone 
una serie de cambios en el estado de la célula que pasa de inactivo a activo, promoviendo la 
migración celular, posibilitando interacciones entre células inmunitarias y la proliferación 
celular que expande la magnitud de la respuesta en curso y apoya sus funciones efectoras. 
 
Una importante vía de señalización en las células B es la vía NF-κB, la cual recibe el nombre 
de las proteínas NF-κB, que son elementales en esta vía y ven su expresión génica alterada 
cuando ésta es activada. La proteína IκBNS regula la actividad de las proteínas NF-κB en el 
núcleo y modula su efecto en el desarrollo y función de las células B. Durante seis años, he 
estudiado el papel que juega IκBNS mediante el uso de ratones que son totalmente deficientes 
en IκBNS, los ratones bumble, y ratones que son deficientes en IκBNS solamente en sus células 
B, los ratones nfkbidB-. 
En el artículo I, reportamos que sin IκBNS hay un subconjunto de células B-1, las células B-
1a, que no se desarrollan. Las células B se originan a partir de células madre que pasan por 
diversas etapas precursoras antes de ser completamente maduras y funcionales. Hemos 
identificado una etapa precursora que principalmente genera células B-1a pero que sin embargo 
estaba ausente en ratones bumble. Las células B-1 responden principalmente a antígenos TI y, 
coherentemente, observamos que ratones bumble eran incapaces de establecer una respuesta 
de anticuerpos contra antígenos TI. 
 
En el artículo II, observamos que la activación de las células B en ratones bumble era 
relativamente normal en las primeras 24 horas pero que la división celular estaba notablemente 
afectada. TACI es un receptor expresado en la superficie de las células B y es esencial para 
llevar a cabo respuesta de anticuerpos TI. Vimos que TACI no se expresaba en la superficie de 
células B bumble y que su expresión tampoco se regulaba al alza eficientemente después de 
haber sido las células activadas. Las células B bumble además eran incapaces de responder a 
las proteínas que se unen a TACI y lo activan. Las células B que están cometidas a convertirse 
en células plasmáticas necesitan modificar su expresión génica para adaptarse a su futura 
función como células secretoras de anticuerpos. La expresión de las proteínas involucradas en 
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estas modificaciones, IRF4 y Blimp-1, era rápidamente inducida en células B bumble. A pesar 
de todo, células B bumble no se convertían en células plasmáticas. Esto sugiere que la 
“sobreactivación” de células B bumble es perjudicial para el proceso de conversión a células 
plasmáticas.  
 
En el artículo III, usamos los ratones nfkbidB- para entender en qué medida IκBNS era 
necesario para una correcta función de las células B durante las respuestas de anticuerpos TD. 
Inmunizamos ratones nfkbidB- con antígenos TD y observamos que, aunque estos ratones son 
capaces de producir anticuerpos, no pueden cambiar el isotipo de éstos, que es el componente 
del anticuerpo que determina su función efectora. Las células T tenían un comportamiento 
normal en estos ratones, sugiriendo así que el rol de IκBNS en las respuestas TD está limitado 
a la diferenciación en célula plasmática y la conmutación de isotipo en las células B.  
 
En el artículo IV, con el conocimiento que adquirimos en los artículos I-III, desarrollamos un 
método para evaluar el proceso de activación de la célula B y generación de células plasmáticas 
en células B humanas. Investigar la generación de células plasmáticas en pacientes que padecen 
enfermedades inmunes nos permitiría obtener una información sobre cómo estas enfermedades 
se desarrollan. Esto sería beneficioso para el proceso diagnóstico e incluso a la hora de 
identificar candidatos adecuados para intervenciones terapéuticas.  
En resumen, el trabajo presentado en esta tesis contribuye al conocimiento que tenemos de los 
procesos fundamentales para las respuestas de anticuerpos efectivas y que son de especial 
relevancia en enfermedades inmunes.  
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